Schizophrenia.
paper
Cited
Public
Unavailable
- Authors
- van Os, Jim; Kapur, Shitij
- Year
- 2009
- Journal
- Lancet (London, England)
- PMID
- 19700006
- DOI
- 10.1016/S0140-6736(09)60995-8
Schizophrenia is still one of the most mysterious and costliest mental disorders in terms of human suffering and societal expenditure. Here, we focus on the key developments in biology, epidemiology, and pharmacology of schizophrenia and provide a syndromal framework in which these aspects can be understood together. Symptoms typically emerge in adolescence and early adulthood. The incidence of the disorder varies greatly across places and migrant groups, as do symptoms, course, and treatment response across individuals. Genetic vulnerability is shared in part with bipolar disorder and recent molecular genetic findings also indicate an overlap with developmental disorders such as autism. The diagnosis of schizophrenia is associated with demonstrable alterations in brain structure and changes in dopamine neurotransmission, the latter being directly related to hallucinations and delusions. Pharmacological treatments, which block the dopamine system, are effective for delusions and hallucinations but less so for disabling cognitive and motivational impairments. Specific vocational and psychological interventions, in combination with antipsychotic medication in a context of community-case management, can improve functional outcome but are not widely available. 100 years after being so named, research is beginning to understand the biological mechanisms underlying the symptoms of schizophrenia and the psychosocial factors that moderate their expression. Although current treatments provide control rather than cure, long-term hospitalisation is not required and prognosis is better than traditionally assumed.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Analyzing the Placebo Response and Identifying Influential Factors in Oral Medication Trials for Acute-Phase Schizophrenia. | Ren J et al. | β | 2026 | β |
| Clozapine treatment during the adolescent period reverses behavioral deficits in a dual-hit mouse model combining prenatal stress and maternal immune activation. | Kim HJ et al. | β | 2026 | β |
| Data-driven schizophrenia subtyping via brain atrophy trajectories and functional connectivity. | Yoshimaru D et al. | β | 2026 | β |
| Deciphering the Heterogeneity of Schizophrenia: A Multimodal and Multivariate Neuroimaging Framework for Unveiling Brain-Symptom Relationships and Underlying Subtypes. | Wei L et al. | β | 2026 | β |
| Genome-Wide by Lifetime Environment Interaction Studies of Brain Imaging Phenotypes. | Wang S et al. | β | 2026 | β |
| Grin2a knockout in adolescent dopamine neurons disrupts prediction error signaling and produces a phenotype relevant to schizophrenia. | Kielhold ML et al. | β | 2026 | β |
| Identification and prioritization of gene sets associated with schizophrenia risk by network analysis. | Yu M et al. | β | 2026 | β |
| Incidence of psychotic disorders by birth cohort: a population-based cohort study in Ontario, Canada. | Myran DT et al. | β | 2026 | β |
| Psychotic-like experiences in adolescents enriched for high-risk for developing severe mental illness: change over two-years and associations with neural reward processing and affective symptoms. | Dong X et al. | β | 2026 | β |
| Study protocol for a randomized clinical pilot trial investigating feasibility and efficacy of augmenting a virtual reality-assisted intervention targeting auditory verbal hallucinations with biofeedback: The Neuro-VR study. | Habla AF et al. | β | 2026 | β |
| SUICIDE AND PSYCHOSIS: Comparing the Characteristics of Patients Who Died by Suicide Following Recent Onset and Longer Duration of Schizophrenia and Other Primary Psychotic Disorders, 2008-2021. | Baird A et al. | β | 2026 | β |
| Targeting the brain through the nose: Advances in polymeric nanoparticle delivery for schizophrenia. | Ponduri TK et al. | β | 2026 | β |
| Aberrant prefrontal-hippocampal connectivity of cross-modal associative memory impairment in schizophrenia. | Zhai Z et al. | β | 2025 | β |
| Alterations in the plasma concentrations of BDNF, proBDNF, and MMP-9 in patients with schizophrenia. | Liang Y et al. | β | 2025 | β |
| Assessing tDCS efficacy in reducing negative symptoms in schizophrenia spectrum disorders: A systematic review and meta-analysis. | Guiomar R et al. | β | 2025 | β |
| A Transcriptome-Wide Mendelian Randomization Study in Isolated Human Immune Cells Highlights Risk Genes Involved in Viral Infections and Potential Drug Repurposing Opportunities for Schizophrenia. | Stacey D et al. | β | 2025 | β |
| Autistic and schizotypal traits influence audiovisual temporal binding window malleability following alpha-band entrainment. | Marsicano G et al. | β | 2025 | β |
| Brain glucose and ketone metabolism in first-episode psychosis: Neuroimaging and brain metabolism before and after antipsychotic treatment: The protocol for the CAST-ATP study. | Zemmour K et al. | β | 2025 | β |
| Causality effect of 21 metals in plasma and serum, 731 immunocytes, and schizophrenia: an intermediary Mendelian randomization study in East Asian populations. | Yang Y et al. | β | 2025 | β |
| CD73 polymorphisms are associated with schizophrenia. | Peng HX et al. | β | 2025 | β |
| [Changing Psychiatric Terms - Why Schizophrenia Needs to be Renamed in the 21st Century]. | BΓΆge K et al. | β | 2025 | β |
| Circular RNAs in neurological conditions - computational identification, functional validation, and potential clinical applications. | Hatzimanolis O et al. | β | 2025 | β |
| Comment on "Deficient audiovisual speech perception in schizophrenia: An ERP study". | Zhang J et al. | β | 2025 | β |
| Comparative analysis of third-generation antipsychotics in first-episode schizophrenia: efficacy, safety, and cognitive impacts. A narrative review. | Ricci V et al. | β | 2025 | β |
| Comparative Effectiveness of Cognitive Behavioral Therapies in Schizophrenia and Schizoaffective Disorder: A Systematic Review and Meta-Regression Analysis. | Karageorgiou V et al. | β | 2025 | β |
| Depressive symptomatology in the first-episode schizophrenia spectrum disorders OPTiMiSE trial: prevalence, correlates, symptom progression and outcomes. | Lopez-Morinigo JD et al. | β | 2025 | β |
| Dermatoglyphics and schizophrenia: A comprehensive review of neurodevelopmental biomarkers. | Bou Farah E et al. | β | 2025 | β |
| Differential gene expression study in whole blood identifies candidate genes for psychosis in African American individuals. | Knowles EEM et al. | β | 2025 | β |
| Does KarXT (xanomeline-trospium) represent a novel approach to schizophrenia management? A GRADE-assessed systematic review and meta-analysis of randomized controlled clinical trials. | Mohammed HE et al. | β | 2025 | β |
| Early psychosis is characterized by white matter abnormalities in fiber structures supporting local connectivity | Saito Y et al. | β | 2025 | β |
| Effectiveness of Sinovac vaccine against SARS-CoV-2 (CoronaVac) in reducing in-hospital mortality in individuals with COVID-19 and schizophrenia: a retrospective cohort study. | Gao Y et al. | β | 2025 | β |
| Efficacy and Safety of Cariprazine, Asenapine, Xanomeline-Trospium, and Lumateperone for Acute Exacerbations of Schizophrenia in Adults: A Network Meta-Analysis. | Abusalameh A et al. | β | 2025 | β |
| Efficacy and Safety of Histamine H3 Receptor Antagonist/Inverse Agonist Including Betahistine for Schizophrenia: A Systematic Review and Meta-Analysis. | Nishii Y et al. | β | 2025 | β |
| Enhanced treatment outcomes for schizophrenia through combined long-acting injectable antipsychotic medications and home visits: retrospective cohort study. | Harada H et al. | β | 2025 | β |
| Exploring the predictive value of structural covariance networks for the diagnosis of schizophrenia. | Vetter CS et al. | β | 2025 | β |
| Five-factor personality traits in patients with schizophrenia and bipolar disorder: a systematic review and meta-analysis. | Hashimoto M et al. | β | 2025 | β |
| From Genetics to Psychosocial Functioning: Unraveling the Mediating Roles of Cognitive Reserve, Cognition, and Negative Symptoms in First-Episode Psychosis. | Forte MF et al. | β | 2025 | β |
| Functional Connectivity in Chronic Schizophrenia: An EEG Resting-State Study with Corrected Imaginary Phase-Locking. | Domingos C et al. | β | 2025 | β |
| Genetic signatures underlining circulating lipids display causal effects on schizophrenia. | Du J et al. | β | 2025 | β |
| Glioinflammation: disease-associated microglia and astrocytes in psychiatric disorders, neurodegeneration, and senescence. | Uemura K et al. | β | 2025 | β |
| Global burden of schizophrenia in 204 countries and regions from 1990 to 2021 and machine learning-based projections to 2036: an analysis of the 2021 global burden of disease study. | Feng Z et al. | β | 2025 | β |
| Glymphatic system dysfunction in young adults hospitalized for an acute psychotic episode: a preliminary report from a pilot study. | Barlattani T et al. | β | 2025 | β |
| Guideline for pharmacological treatment of schizophrenia 2022. | Japanese Society of Neuropsychopharmacology et al. | β | 2025 | β |
| Identifying neurobiological heterogeneity in clinical high-risk psychosis: a data-driven biotyping approach using resting-state functional connectivity. | Tang X et al. | β | 2025 | β |
| Infant rat ultrasonic vocalizations in the neurodevelopmental model of schizophrenia. | Potasiewicz A et al. | β | 2025 | β |
| Influence of antipsychotic drugs on microglia-mediated neuroinflammation in schizophrenia: perspectives in an astrocyte-microglia co-culture model. | Faustmann TJ et al. | β | 2025 | β |
| Integrated bioinformatics and machine learning identify S100A9 and VGLL1 as hub genes for schizophrenia. | Lv J et al. | β | 2025 | β |
| Integrating genetic regulation and schizophrenia-specific splicing quantitative expression with GWAS prioritizes novel risk genes for schizophrenia. | Li X et al. | β | 2025 | β |
| Investigating Connectivity Gradients in Schizophrenia: Integrating Functional, Structural, and Genetic Perspectives. | Xiang J et al. | β | 2025 | β |
| Left amygdala alterations mediate the effects of negative symptoms on social dysfunction in schizophrenia. | Fang J et al. | β | 2025 | β |
| LncRNA-miRNAβmRNA Network in Schizophrenia. | Long J et al. | β | 2025 | β |
| Long non-coding RNAs in schizophrenia. | Mousavinejad SN et al. | β | 2025 | β |
| Managing schizophrenia with affective, sexual, metabolic and substance-use comorbidities: pharmacological considerations from an expert consensus. | Vieta E et al. | β | 2025 | β |
| Mismatch negativity deficits in schizophrenia and bipolar disorder. | Du L et al. | β | 2025 | β |
| Multimode neural population coding of diverse innate fear response by mitral and tufted cells. | Xu H et al. | β | 2025 | β |
| Narcolepsy and psychiatric comorbidity: a review of the literature. | Verstraete L et al. | β | 2025 | β |
| Network pharmacology and molecular docking to explore mechanisms of clozapine-induced cardiac arrest. | Chen X et al. | β | 2025 | β |
| Neurocognition as a major predictor of 8-week response to antipsychotics for drug-naΓ―ve first-episode schizophrenia using machine learning. | Wang X et al. | β | 2025 | β |
| Neuroendocrine characterization into schizophrenia: norepinephrine and melatonin as promising biomarkers. | Shen J et al. | β | 2025 | β |
| Neuroglial Advances: New Roles for Established Players. | Verkhratsky A et al. | β | 2025 | β |
| Neurostructural, Neurofunctional, and Clinical Features of Chronic, Untreated Schizophrenia: A Narrative Review. | Tang B et al. | β | 2025 | β |
| Non-bivalent psychopathology: Rethinking mental disorders through metacontrol. | Colzato L et al. | β | 2025 | β |
| Plasma profiles of neurology-related proteins in at-risk mental state and first-episode psychosis: Associations with psychotic symptoms and cognitive performance. | Llaurador-Coll M et al. | β | 2025 | β |
| Quality of Life in Caregivers of Patients with Schizophrenia: A Systematic Review of the Impact of Sociodemographic, Clinical, and Psychological Factors. | Gagiu C et al. | β | 2025 | β |
| Rapid treatment initiation in patients with schizophrenia: evaluation of the clinical and functional outcomes of the two-injection start regimen of aripiprazole once-monthly. | YΔ±lmaz Y et al. | β | 2025 | β |
| Risk of psychosis following mild traumatic brain injury: a systematic review and meta-analysis. | Aguda A et al. | β | 2025 | β |
| Role of peripheral cytokines and orbitofrontal cortex subregion structure in schizophrenia agitation. | Dong Y et al. | β | 2025 | β |
| Schizophrenia in Autistic People with Intellectual Disabilities. Treatment and Interventions. | Bakken TL et al. | β | 2025 | β |
| Sex differences in insomnia and hypersomnia complaints during major depressive episode: Results from a national sample. | Geoffroy PA et al. | β | 2025 | β |
| Structural Basis for D3/D4-Selective Antagonism of Piperazinylalkyl Pyrazole/Isoxazole Analogs. | Choi KE et al. | β | 2025 | β |
| Synergistic SNP-SNP interaction of NRG1 and ERBB4 increases the risk of schizophrenia. | Norovsambuu O et al. | β | 2025 | β |
| The antipsychotic chlorpromazine reduces neuroinflammation by inhibiting microglial voltage-gated potassium channels. | Lee HY et al. | β | 2025 | β |
| The Cross-Sectional and Longitudinal Effects of Cumulative Multi-Contextual Risk on Psychotic-Like Experiences among Chinese Rural Adolescents. | Yang J et al. | β | 2025 | β |
| The Role of Astrocytes in the Molecular Pathophysiology of Schizophrenia: Between Neurodevelopment and Neurodegeneration. | Vellucci L et al. | β | 2025 | β |
| The study on agitation and structure of orbitofrontal cortex subregion in first-episode drug-naΓ―ve patients with schizophrenia. | Dong Y et al. | β | 2025 | β |
| Transdiagnostic modeling of clinician-rated symptoms in affective and nonaffective psychotic disorders. | Chung Y et al. | β | 2025 | β |
| Transient juvenile demyelination impairs maturation and function of parvalbumin-positive interneurons in the prefrontal cortex. | Hijazi S et al. | β | 2025 | β |
| Using machine learning to predict persecutory beliefs based on aetiological models of delusions identified in a systematic literature search. | Denecke S et al. | β | 2025 | β |
| A Global, Regional, and National Burden and Quality of Care Index for Schizophrenia: Global Burden of Disease Systematic Analysis 1990-2019. | Same K et al. | β | 2024 | β |
| Antipsychotic Treatment in People at Clinical High Risk for Psychosis: A Narrative Review of Suggestions for Clinical Practice. | Di Lisi A et al. | β | 2024 | β |
| A prefrontal thalamocortical readout for conflict-related executive dysfunction in schizophrenia. | Huang AS et al. | β | 2024 | β |
| Association of polygenic liabilities for schizophrenia and bipolar disorder with educational attainment and cognitive aging. | Wu CS et al. | β | 2024 | β |
| Associations between residential environments and late-onset schizophrenia in UK Biobank: Interaction with genetic risk factor. | Shen C et al. | β | 2024 | β |
| Bipolar disorders and schizophrenia: discrete disorders? | Dines M et al. | β | 2024 | β |
| Circulating microRNA Profiles Identify a Patient Subgroup with High Inflammation and Severe Symptoms in Schizophrenia Experiencing Acute Psychosis. | Miyano T et al. | β | 2024 | β |
| Comparative efficacy of different types of exercise modalities on psychiatric symptomatology in patients with schizophrenia: a systematic review with network meta-analysis. | Cui W et al. | β | 2024 | β |
| Connectome architecture shapes large-scale cortical alterations in schizophrenia: a worldwide ENIGMA study. | Georgiadis F et al. | β | 2024 | β |
| Depressive and anxiety symptoms among schizophrenia patients. | Zhao M et al. | β | 2024 | β |
| Diverging functional connectivity timescales: Capturing distinct aspects of cognitive performance in early psychosis. | Hirsch F et al. | β | 2024 | β |
| DRD4 VNTR 4/4 homozygosity as a genetic biomarker for treatment selection in patients with schizophrenia. | Yang HM et al. | β | 2024 | β |
| Duration mismatch negativity under varying deviant conditions in individuals with high schizotypal traits. | Deng J et al. | β | 2024 | β |
| Early intervention in psychosis in low- and middle-income countries: Applying the same principles as the developed countries. | Nasrallah HA | β | 2024 | β |
| Effects of long-term antipsychotic medication on brain instability in first-episode schizophrenia patients: a resting-state fMRI study. | Zhong M et al. | β | 2024 | β |
| Electromyographic Characteristics of Postactivation Effect in Dopamine-Dependent Spectrum Models Observed in Parkinson's Disease and Schizophrenia. | Meigal A et al. | β | 2024 | β |
| Elevated plasma matrix metalloproteinase 9 in schizophrenia patients associated with poor antipsychotic treatment response and white matter density deficits. | Li X et al. | β | 2024 | β |
| Excitation/inhibition imbalance in schizophrenia: a meta-analysis of inhibitory and excitatory TMS-EMG paradigms. | LΓ‘nyi O et al. | β | 2024 | β |
| From Reactive to Proactive - The Future Life Design to Promote Health and Extend the Human Lifespan. | Yao L et al. | β | 2024 | β |
| Gene expression changes in Brodmann's Area 46 differentiate epidermal growth factor and immune system interactions in schizophrenia and mood disorders. | Ketharanathan T et al. | β | 2024 | β |
| Glia dysfunction in schizophrenia: evidence of possible therapeutic effects of nervonic acid in a preclinical model. | Wang X et al. | β | 2024 | β |
| Incidence and Risk Profiles for Suicide Mortality in Patients With Schizophrenia Receiving Homecare Case Management in Taiwan. | Chen WY et al. | β | 2024 | β |
| Individualized Texture Similarity Network in Schizophrenia. | Ding H et al. | β | 2024 | β |
| Investigating Cannabidiol's potential as a supplementary treatment for schizophrenia: A narrative review. | Denis VΓΆlker JS et al. | β | 2024 | β |
| Male-biased vulnerability of mouse brain tryptophan/kynurenine and glutamate systems to adolescent exposures to concentrated ambient ultrafine particle air pollution. | Cory-Slechta DA et al. | β | 2024 | β |
| Mechanism of electroconvulsive therapy in schizophrenia: a bioinformatics analysis study of RNA-seq data. | Wang T et al. | β | 2024 | β |
| Mechanisms of vagus nerve stimulation for the treatment of neurodevelopmental disorders: a focus on microglia and neuroinflammation. | Gargus M et al. | β | 2024 | β |
| Music Matters - A Qualitative Evaluation of a Nurse-Led, Group-Based Music Program Complementary to Early Intervention for First-Episode Psychosis. | Abild SM et al. | β | 2024 | β |
| Network Localization of State and Trait of Auditory Verbal Hallucinations in Schizophrenia. | Mo F et al. | β | 2024 | β |
| Plasma microRNAs Associate Positive, Negative, and Cognitive Symptoms with Inflammation in Schizophrenia. | Miyano T et al. | β | 2024 | β |
| Proteomic profiling in the progression of psychosis: Analysis of clinical high-risk, first episode psychosis, and healthy controls. | Lee H et al. | β | 2024 | β |
| Psychiatric Manifestations in Children and Adolescents with Inherited Metabolic Diseases. | Baglioni V et al. | β | 2024 | β |
| Schizophrenia in the genetic era: a review from development history, clinical features and genomic research approaches toΒ insights of susceptibility genes. | Lv Y et al. | β | 2024 | β |
| SEP-363856 exerts neuroprotection through the PI3K/AKT/GSK-3Ξ² signaling pathway in a dual-hit neurodevelopmental model of schizophrenia-like mice. | Li M et al. | β | 2024 | β |
| Sex-dependent association study of complement C4 gene with treatment-resistant schizophrenia and hospitalization frequency. | Teymouri K et al. | β | 2024 | β |
| Sex-Dependent Attentional Impairments in a Subchronic Ketamine Mouse Model for Schizophrenia. | Spark DL et al. | β | 2024 | β |
| Sex differences in autonomic adverse effects related to antipsychotic treatment and associated hormone profiles. | Johansen IT et al. | β | 2024 | β |
| Shaping tomorrow's support: baseline clinical characteristics predict later social functioning and quality of life in schizophrenia spectrum disorder. | Hao J et al. | β | 2024 | β |
| Statins as an adjuvant therapy for patients with schizophrenia: An up-to-date systematic review and meta-analysis. | Peng TR et al. | β | 2024 | β |
| Study protocol for RUFUS-A randomized mixed methods pilot clinical trial investigating the relevance and feasibility of rumination-focused cognitive behavioral therapy in the treatment of patients with emergent psychosis spectrum disorders. | Clemmensen L et al. | β | 2024 | β |
| Substance use and lifestyle risk factors for somatic disorders among psychiatric patients in Greenland. | Nielsen IM et al. | β | 2024 | β |
| The association between symptomatic remission and social support in community-dwelling schizophrenia patients during COVID-19. | Yao L et al. | β | 2024 | β |
| The causal relationship between immune cell traits and schizophrenia: a Mendelian randomization analysis. | Du J et al. | β | 2024 | β |
| The Correlation Between Peripheral Blood Micro-Ribonucleic Acid Expression Level and Personality Disorder in Patients with Schizophrenia. | Wei H et al. | β | 2024 | β |
| The Cost-Effectiveness of a Novel Online Social Therapy to Maintain Treatment Effects From First-Episode Psychosis Services: Results From the Horyzons Randomized Controlled Trial. | Engel L et al. | β | 2024 | β |
| The effect of childhood trauma on moral cognition in patients with schizophrenia. | Peng X et al. | β | 2024 | β |
| The effect of phencyclidine-mediated blockade of NMDA receptors in the early postnatal period on glutathione and sulfur amino acid levels in the rat brain as a potential causative factor of schizophrenia-like behavior in adulthood. | Lorenc-Koci E et al. | β | 2024 | β |
| The effect of second-generation antipsychotics on anxiety/depression in patients with schizophrenia: A systematic review and meta-analysis. | Abdolizadeh A et al. | β | 2024 | β |
| The effects of ketogenic metabolic therapy on mental health and metabolic outcomes in schizophrenia and bipolar disorder: a randomized controlled clinical trial protocol. | Longhitano C et al. | β | 2024 | β |
| The relationship between hot temperatures and hospital admissions for psychosis in adults diagnosed with schizophrenia: A case-crossover study in Quebec, Canada. | Tupinier Martin F et al. | β | 2024 | β |
| The role of SIRT3 in mediating the cognitive deficits and neuroinflammatory changes associated with a developmental animal model of schizophrenia. | Hao K et al. | β | 2024 | β |
| Theta Burst Stimulation Protocols for Schizophrenia: A Systematic Review and Network Meta-Analysis. | Kishi T et al. | β | 2024 | β |
| The Transdiagnostic Global Impression - Psychopathology scale (TGI-P): Initial development of a novel transdiagnostic tool for assessing, tracking, and visualising psychiatric symptom severity in everyday practice. | Correll CU et al. | β | 2024 | β |
| Traversing the epigenetic landscape: DNA methylation from retina to brain in development and disease. | Xu C et al. | β | 2024 | β |
| Activation of the left medial temporal gyrus and adjacent brain areas during affective theory of mind processing correlates with trait schizotypy in a nonclinical population. | Vucurovic K et al. | β | 2023 | β |
| Alteration of Gut Microbiome in Patients With Schizophrenia Indicates Links Between Bacterial Tyrosine Biosynthesis and Cognitive Dysfunction. | Thirion F et al. | β | 2023 | β |
| Anatomical variations in the insular cortex in individuals at a clinical high-risk state for psychosis and patients with schizophrenia. | Takahashi T et al. | β | 2023 | β |
| An evolutionary account of impairment of self in cognitive disorders. | BenΓtez-Burraco A et al. | β | 2023 | β |
| Antiviral treatment in schizophrenia: a randomized pilot PET study on the effects of valaciclovir on neuroinflammation. | Jonker I et al. | β | 2023 | β |
| A pilot 1-year follow-up randomised controlled trial comparing metacognitive training to psychoeducation in schizophrenia: effects on insight. | Lopez-Morinigo JD et al. | β | 2023 | β |
| Association between thyroid function and psychotic symptoms in adolescents with major depressive disorder: A large sample sized cross-sectional study in China. | Yang R et al. | β | 2023 | β |
| Association of the <i>CDH13</i> gene variant rs9940180 with schizophrenia risk in North Indian population. | Gupta S et al. | β | 2023 | β |
| Association Study Between White Matter Microstructure and Intelligence Decline in Schizophrenia. | Matsumoto J et al. | β | 2023 | β |
| Astrocytic cell adhesion genes linked to schizophrenia correlate with synaptic programs in neurons. | PietilΓ€inen O et al. | β | 2023 | β |
| A study on the changing trend and influencing factors of hospitalization costs of schizophrenia in economically underdeveloped areas of China. | Li J et al. | β | 2023 | β |
| Automatic identification of schizophrenia employing EEG records analyzed with deep learning algorithms. | Soria Bretones C et al. | β | 2023 | β |
| Biological evaluation and <i>in silico</i> studies of novel compounds as potent TAAR1 agonists that could be used in schizophrenia treatment. | Wang Y et al. | β | 2023 | β |
| Brain-Derived Neurotrophic Factor Val66Met Genotype Modulates Latent Inhibition: Relevance for Schizophrenia. | Buhusi M et al. | β | 2023 | β |
| Brain Structural Changes in Schizophrenia Patients Compared to the Control: An MRI-based Cavalieri's Method. | Heidari Z et al. | β | 2023 | β |
| Cariprazine for treating coprophagia and organic psychosis in a young woman with acquired brain injury. | Collison-Ani E et al. | β | 2023 | β |
| Case report: Successful administration of cariprazine in a young, severely ill patient with recurrent relapses of schizophrenia and persistent negative symptoms. | Vrublevska J | β | 2023 | β |
| Causal link between thyroid function and schizophrenia: a two-sample Mendelian randomization study. | Freuer D et al. | β | 2023 | β |
| Characterization and prediction of individual functional outcome trajectories in schizophrenia spectrum disorders (PREDICTS study): Study protocol. | Agarwal SM et al. | β | 2023 | β |
| Communicating diagnoses to individuals with a first episode psychosis: A qualitative study of individuals perspectives. | Huurman ME et al. | β | 2023 | β |
| Comprehensive bioinformatics analysis and molecular validation of lncRNAs-mediated ceRNAs network in schizophrenia. | Wang J et al. | β | 2023 | β |
| Contemporary Role of Stereotactic Radiosurgery for Psychiatric Disorders. | Sadashiva N et al. | β | 2023 | β |
| Dietary total antioxidant capacity and serum 8-OHdG in patients with schizophrenia. | KaragΓΆl G et al. | β | 2023 | β |
| Dissecting Schizotypy and Its Association With Cognition and Polygenic Risk for Schizophrenia in a Nonclinical Sample. | Tiego J et al. | β | 2023 | β |
| Does chronic use of amphetamine-type stimulants impair interference control? - A meta-analysis. | Opitz A et al. | β | 2023 | β |
| Dopamine D3 Receptor, Cognition and Cognitive Dysfunctions in Neuropsychiatric Disorders: From the Bench to the Bedside. | Torrisi SA et al. | β | 2023 | β |
| Dual orexin/hypocretin receptor antagonism attenuates NMDA receptor hypofunction-induced attentional impairments in a rat model of schizophrenia. | Maness EB et al. | β | 2023 | β |
| Effects of urban particulate matter on gut microbiome and partial schizophrenia-like symptoms in mice: Evidence from shotgun metagenomic and metabolomic profiling. | Yi W et al. | β | 2023 | β |
| Efficacy and safety of adjunctive therapy with fingolimod in patients with schizophrenia: A randomized, double-blind, placebo-controlled clinical trial. | Karbalaee M et al. | β | 2023 | β |
| Factors Contributing to Risk of Persistence of Positive and Negative Symptoms in Schizophrenia during Hospitalization. | Witkowski G et al. | β | 2023 | β |
| [Factors Influencing Suicide Deaths in Patients With Schizophrenia Based on Cohort Data: An Empirical Study of a Sample of 170006 Patients in Sichuan Province]. | Li S et al. | β | 2023 | β |
| Functional Nutrition as Integrated Intervention for In- and Outpatient with Schizophrenia. | Matrisciano F | β | 2023 | β |
| Genetic regulatory and biological implications of the 10q24.32 schizophrenia risk locus. | Wang J et al. | β | 2023 | β |
| Genomic findings in schizophrenia and their implications. | Owen MJ et al. | β | 2023 | β |
| Genomic insights into schizophrenia. | Owen MJ | β | 2023 | β |
| Higher stress response and altered quality of life in schizophrenia patients with low membrane levels of docosahexaenoic acid. | Adrien V et al. | β | 2023 | β |
| Identification of Plasma Biomarkers in Drug-NaΓ―ve Schizophrenia Using Targeted Metabolomics. | Su Q et al. | β | 2023 | β |
| Influence of Antipsychotic Agents on the Sexuality of Patients Diagnosed with Schizophrenia. | Fares J et al. | β | 2023 | β |
| Investigating the symptomatic and morphological changes in the brain based on pre and post-treatment: A critical review from clinical to neuroimaging studies on schizophrenia. | Chatterjee I et al. | β | 2023 | β |
| Prenatal nicotine exposure during pregnancy results in adverse neurodevelopmental alterations and neurobehavioral deficits. | Wells AC et al. | β | 2023 | β |
| Prognostic and immunomodulatory roles of schizophrenia-associated genes HTR2A, COMT, and PRODH in pan-cancer analysis and glioma survival prediction model. | Shen J et al. | β | 2023 | β |
| Revisiting reward impairments in schizophrenia spectrum disorders: a systematic review and meta-analysis for neuroimaging findings. | Wang X et al. | β | 2023 | β |
| Role of Ayurveda in the management of psychotic disorders: A systematic review of clinical evidence. | Kulamarva K et al. | β | 2023 | β |
| Schizophrenia and Glutathione: A Challenging Story. | Carletti B et al. | β | 2023 | β |
| Schizophrenia in autistic people with intellectual disabilities: Symptom manifestations and identification. | Bakken TL et al. | β | 2023 | β |
| Shotgun metagenomics reveals abnormal short-chain fatty acid-producing bacteria and glucose and lipid metabolism of the gut microbiota in patients with schizophrenia. | Li Z et al. | β | 2023 | β |
| Strategies for Alleviating the Burden Experienced by Informal Caregivers of Persons With Severe Mental Disorders in Transitional Countries: Protocol for a Scoping Review. | Silaule O et al. | β | 2023 | β |
| Sustained specialized and family treatment in first-episode schizophrenia or related disorders: a 5-year randomized controlled trial. | de Haan L et al. | β | 2023 | β |
| The Effect of Lieberman Community Return Program on Reducing Positive and Negative Symptoms and Improving Social Skills in Patients with Schizophrenia. | Emami M et al. | β | 2023 | β |
| The emerging role of exosomes in Schizophrenia. | Dai J et al. | β | 2023 | β |
| The use of theta burst stimulation in patients with schizophrenia - A systematic review. | Poorganji M et al. | β | 2023 | β |
| Understanding and Managing Cognitive Distortions in Individuals With Schizophrenia. | Verma KK | β | 2023 | β |
| Vortioxetine improved negative and cognitive symptoms of schizophrenia in subchronic MK-801 model in rats. | Bozkurt NM et al. | β | 2023 | β |
| Aberrant Functional Connectivity of the Orbitofrontal Cortex Is Associated With Excited Symptoms in First-Episode Drug-NaΓ―ve Patients With Schizophrenia. | Chen C et al. | β | 2022 | β |
| Abnormal functional connectivity of the striatum in first-episode drug-naive early-onset Schizophrenia. | Zhang Y et al. | β | 2022 | β |
| Abnormal synaptic plasticity and impaired cognition in schizophrenia. | Wu XL et al. | β | 2022 | β |
| A Cross-Sectional Study on Associations Between BDNF, CRP, IL-6 and Clinical Symptoms, Cognitive and Personal Performance in Patients With Paranoid Schizophrenia. | Chumakov E et al. | β | 2022 | β |
| Activation of basolateral amygdala to anterior cingulate cortex circuit alleviates MK-801 induced social and cognitive deficits of schizophrenia. | Huang X et al. | β | 2022 | β |
| Adherence to Antipsychotic Drugs by Medication Possession Ratio for Schizophrenia and Similar Psychotic Disorders in the Republic of Korea: A Retrospective Cohort Study. | Cho SJ et al. | β | 2022 | β |
| Adolescent nicotine potentiates the inhibitory effect of raclopride, a D<sub>2</sub>R antagonist, on phencyclidine-sensitized psychotic-like behavior in mice. | Dutra-Tavares AC et al. | β | 2022 | β |
| Advantages and Limitations of Animal Schizophrenia Models. | BiaΕoΕ M et al. | β | 2022 | β |
| Affective symptom dimensions in early-onset psychosis over time: a principal component factor analysis of the Young Mania Rating Scale and the Hamilton Depression Rating Scale. | Salazar de Pablo G et al. | β | 2022 | β |
| An Integrated Pharmacokinetic-Pharmacodynamic-Pharmacoeconomic Modeling Method to Evaluate Treatments for Adults with Schizophrenia. | Piena MA et al. | β | 2022 | β |
| Applications of innovative technologies to the delivery of antipsychotics. | Bergonzi MC et al. | β | 2022 | β |
| Atypical Treatment Switches in Schizophrenia Patients: Drivers and Associated Outcomes. | Khandker R et al. | β | 2022 | β |
| Cognitive behavioural therapy (group) for schizophrenia. | Guaiana G et al. | β | 2022 | β |
| Crosstalk between Schizophrenia and Metabolic Syndrome: The Role of Oxytocinergic Dysfunction. | Goh KK et al. | β | 2022 | β |
| Deficit Symptomatology of Schizophrenia Is Associated with Attenuated Taste Identification: Findings from a Cross-Sectional Study. | WroΕski M et al. | β | 2022 | β |
| Detection of functional and structural brain alterations in female schizophrenia using elastic net logistic regression. | Wu Y et al. | β | 2022 | β |
| Diagnostic Value of Microarray Method in Autism Spectrum Disorder, Intellectual Disability, and Multiple Congenital Anomalies and Some Candidate Genes for Autism: Experience of Two Centers. | Ayaz A et al. | β | 2022 | β |
| Digital smartphone intervention to recognise and manage early warning signs in schizophrenia to prevent relapse: the EMPOWER feasibility cluster RCT. | Gumley AI et al. | β | 2022 | β |
| Dynamic symptom networks across different at-risk stages for psychosis: An individual and transdiagnostic perspective. | van der Tuin S et al. | β | 2022 | β |
| Early Schizophrenia and Bipolar Disorder Patients Display Reduced Neural Prepulse Inhibition. | San-Martin R et al. | β | 2022 | β |
| Efficacy of a gluten-restricted diet in treatment-resistant schizophrenia patients with immunological gluten sensitivity: A case report. | Motoyama M et al. | β | 2022 | β |
| E-Prevention: Advanced Support System for Monitoring and Relapse Prevention in Patients with Psychotic Disorders Analyzing Long-Term Multimodal Data from Wearables and Video Captures. | Zlatintsi A et al. | β | 2022 | β |
| Evaluating the tendencies of community practitioners who actively practice in child and adolescent psychiatry to diagnose and treat DSM-5 attenuated psychotic syndrome. | Yilmaz Kafali H et al. | β | 2022 | β |
| Exome sequencing of Japanese schizophrenia multiplex families supports the involvement of calcium ion channels. | Toyama M et al. | β | 2022 | β |
| Exploring the trend of Schizophrenia at Hiwot Fana specialized university referral hospital, Eastern, Ethiopia (2016-2020): A 5-year retrospective analysis. | Mohammed F et al. | β | 2022 | β |
| Exposure to Circadian Disruption During Adolescence Interacts With a Genetic Risk Factor to Modify Schizophrenia-relevant Behaviors in a Sex-dependent Manner. | Cloutier MΓ et al. | β | 2022 | β |
| Facial Emotion Recognition in Psychosis and Associations With Polygenic Risk for Schizophrenia: Findings From the Multi-Center EU-GEI Case-Control Study. | Tripoli G et al. | β | 2022 | β |
| Genetic association between circulating selenium level and the risk of schizophrenia in the European population: A two-sample Mendelian randomization study. | Deng MG et al. | β | 2022 | β |
| High Risk, High Dose?-Pharmacotherapeutic Prescription Patterns of Offender and Non-Offender Patients with Schizophrenia Spectrum Disorder. | Machetanz L et al. | β | 2022 | β |
| Hippocampal Subfield Volumes and Cognitive Function in Schizophrenia and Mood Disorders. | Yasuda K et al. | β | 2022 | β |
| Influences on the Genetic Relationship Between Cannabis Use and Schizophrenia: The Role of the Externalizing Spectrum. | Wormington B et al. | β | 2022 | β |
| Insulin-like Growth Factor 2 (IGF-2) and Insulin-like Growth Factor Binding Protein 7 (IGFBP-7) Are Upregulated after Atypical Antipsychotics in Spanish Schizophrenia Patients. | FernΓ‘ndez-Pereira C et al. | β | 2022 | β |
| Joint-Tissue Integrative Analysis Identified Hundreds of Schizophrenia Risk Genes. | Wu Y et al. | β | 2022 | β |
| Loss of the Schizophrenia-Linked Furin Protein from <i>Drosophila</i> Mushroom Body Neurons Results in Antipsychotic-Reversible Habituation Deficits. | Foka K et al. | β | 2022 | β |
| LY395756 promotes NR2B expression via activation of AKT/CREB signaling in the juvenile methylazoxymethanol mice model of schizophrenia. | Li ML et al. | β | 2022 | β |
| Medication adherence among community-dwelling schizophrenia patients during the COVID-19 pandemic: A cross-sectional study. | Yao L et al. | β | 2022 | β |
| Mental health conditions and use of rhythm control therapies in patients with atrial fibrillation: a nationwide cohort study. | Teppo K et al. | β | 2022 | β |
| Modern neurosurgical techniques for psychiatric disorders. | De Salles A et al. | β | 2022 | β |
| Morphometric Integrated Classification Index: A Multisite Model-Based, Interpretable, Shareable and Evolvable Biomarker for Schizophrenia. | Xie Y et al. | β | 2022 | β |
| Multimodal Magnetic Resonance Imaging Reveals Aberrant Brain Age Trajectory During Youth in Schizophrenia Patients. | Huang J et al. | β | 2022 | β |
| Multitarget Derivatives of D2AAK1 as Potential Antipsychotics: The Effect of Substitution in the Indole Moiety. | Kondej M et al. | β | 2022 | β |
| Neuroinflammation and oxidative stress in schizophrenia: are these opportunities for repurposing? | Ansari Z et al. | β | 2022 | β |
| Neuronal oscillations: early biomarkers of psychiatric disease? | GΓΌnther A et al. | β | 2022 | β |
| Optical Coherence Tomography Angiography in Schizophrenia. | Hanifi KokaΓ§ya M et al. | β | 2022 | β |
| Pattern of predictive features of continued cannabis use in patients with recent-onset psychosis and clinical high-risk for psychosis. | Penzel N et al. | β | 2022 | β |
| Pharmacological effects and therapeutic potential of natural compounds in neuropsychiatric disorders: An update. | Asgharian P et al. | β | 2022 | β |
| Pharmacological interventions for prevention of weight gain in people with schizophrenia. | Agarwal SM et al. | β | 2022 | β |
| Polysialylation in a DISC1 Mutant Mouse. | Takahashi Y et al. | β | 2022 | β |
| Progress and Pitfalls in Developing Agents to Treat Neurocognitive Deficits Associated with Schizophrenia. | VeselinoviΔ T et al. | β | 2022 | β |
| Quetiapine Ameliorates MIA-Induced Impairment of Sensorimotor Gating: Focus on Neuron-Microglia Communication and the Inflammatory Response in the Frontal Cortex of Adult Offspring of Wistar Rats. | Chamera K et al. | β | 2022 | β |
| Relationship Between Cognitive Functions and Decision-Making Capacity in Older Institutionalized Patients with Schizophrenia: A Preliminary Study. | Sugawara N et al. | β | 2022 | β |
| Relationship between White Matter Alterations and Pathophysiological Symptoms in Patients with Ultra-High Risk of Psychosis, First-Episode, and Chronic Schizophrenia. | Waszczuk K et al. | β | 2022 | β |
| Risperidone Induced Hyperprolactinemia: From Basic to Clinical Studies. | Stojkovic M et al. | β | 2022 | β |
| Role of interaction of mGlu2 and 5-HT<sub>2A</sub> receptors in antipsychotic effects. | Ibi D | β | 2022 | β |
| The association between clinical symptoms and later subjective quality of life in individuals with ultra-high risk for psychosis and recent-onset psychotic disorder: A longitudinal investigation. | Usui K et al. | β | 2022 | β |
| The Protective Effect of Social Reward on Opioid and Psychostimulant Reward and Relapse: Behavior, Pharmacology, and Brain Regions. | Venniro M et al. | β | 2022 | β |
| The role of neuronavigation in TMS-EEG studies: Current applications and future perspectives. | Lioumis P et al. | β | 2022 | β |
| The Role of OXT, OXTR, AVP, and AVPR1a Gene Expression in the Course of Schizophrenia. | Broniarczyk-Czarniak M et al. | β | 2022 | β |
| The Role of Transposable Elements of the Human Genome in Neuronal Function and Pathology. | Chesnokova E et al. | β | 2022 | β |
| The Toxicity Potential of Antidepressants and Antipsychotics in Relation to Other Medication and Alcohol: A Naturalistic and Retrospective Study. | Swoboda MMM et al. | β | 2022 | β |
| Toxoplasma infection in male mice alters dopamine-sensitive behaviors and host gene expression patterns associated with neuropsychiatric disease. | Cromar GL et al. | β | 2022 | β |
| Transcranial Ultrasound Stimulation Reverses Behavior Changes and the Expression of Calcium-Binding Protein in a Rodent Model of Schizophrenia. | Tsai CW et al. | β | 2022 | β |
| Treatment Effect of Long-Term Antipsychotics on Default-Mode Network Dysfunction in Drug-NaΓ―ve Patients With First-Episode Schizophrenia: A Longitudinal Study. | Deng M et al. | β | 2022 | β |
| Understanding MMPI-2 response structure between schizophrenia and healthy individuals. | Hsu YC et al. | β | 2022 | β |
| Understanding the Role of the Gut Microbiome in Brain Development and Its Association With Neurodevelopmental Psychiatric Disorders. | Dash S et al. | β | 2022 | β |
| Validity, reliability and clinical utility of mental disorders: The case of ICD-11 schizophrenia. | Valle R | β | 2022 | β |
| Waving Through the Window: A Model of Volitional Social Interaction in Female Mice. | Ramsey LA et al. | β | 2022 | β |
| White matter correlates of impulsivity in frontal lobe and their associations with treatment response in first-episode schizophrenia. | Jung HY et al. | β | 2022 | β |
| [Accountability of anti-cholinergic drugs in increase of psychotic episodes: A case of tropatepine overdose]. | Jaussaud C et al. | β | 2021 | β |
| Altered interhemispheric signal propagation in schizophrenia and depression. | Hui J et al. | β | 2021 | β |
| A Meta-Analysis of the Influence of Antipsychotics on Cytokines Levels in First Episode Psychosis. | Marcinowicz P et al. | β | 2021 | β |
| A new 3-hit mouse model of schizophrenia built on genetic, early and late factors. | Bouet V et al. | β | 2021 | β |
| Anger Experience and Anger Expression Through Drawing in Schizophrenia: An fNIRS Study. | Yan W et al. | β | 2021 | β |
| Antipsychotic patterns in outpatients with schizophrenia in China: A cross sectional study. | Guo X et al. | β | 2021 | β |
| "Apples and pears are similar, but still different things." Bipolar disorder and schizophrenia- discrete disorders or just dimensions ? | Grunze H et al. | β | 2021 | β |
| Assessing olfactory, memory, social and circadian phenotypes associated with schizophrenia in a genetic model based on Rim. | Hidalgo S et al. | β | 2021 | β |
| Association between global visual scanning and cognitive function in schizophrenia. | Huang W et al. | β | 2021 | β |
| Associations of Caregiving Knowledge and Skills With Caregiver Burden, Psychological Well-Being, and Coping Styles Among Primary Family Caregivers of People Living With Schizophrenia in China. | Zhou Z et al. | β | 2021 | β |
| Association study between genetic variants and the risk of schizophrenia in the Chinese population based on GWAS-implicated 6p21.3-23.1 human genome region: a case-control study. | Li G et al. | β | 2021 | β |
| Asymmetry in the Central Nervous System: A Clinical Neuroscience Perspective. | Mundorf A et al. | β | 2021 | β |
| A systematic review of TMS and neurophysiological biometrics in patients with schizophrenia. | di Hou M et al. | β | 2021 | β |
| A transient developmental increase in prefrontal activity alters network maturation and causes cognitive dysfunction in adult mice. | Bitzenhofer SH et al. | β | 2021 | β |
| BDNF haploinsufficiency induces behavioral endophenotypes of schizophrenia in male mice that are rescued by enriched environment. | Harb M et al. | β | 2021 | β |
| Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13. | Falvella ACB et al. | β | 2021 | β |
| Cerebrospinal fluid abnormalities in first- and multi-episode schizophrenia-spectrum disorders: impact of clinical and demographical variables. | Oviedo-Salcedo T et al. | β | 2021 | β |
| Changes in Brain Structure, Function, and Network Properties in Patients With First-Episode Schizophrenia Treated With Antipsychotics. | Yin P et al. | β | 2021 | β |
| Characterization and prediction of clinical pathways of vulnerability to psychosis through graph signal processing. | Sandini C et al. | β | 2021 | β |
| Characterization of affective lability across subgroups of psychosis spectrum disorders. | HΓΈegh MC et al. | β | 2021 | β |
| Chemical analysis of the human brain by imaging mass spectrometry. | Ajith A et al. | β | 2021 | β |
| Classification of Schizophrenia by Combination of Brain Effective and Functional Connectivity. | Zhao Z et al. | β | 2021 | β |
| Clinical evaluation of patients with a neuropsychiatric risk copy number variant. | Chawner SJ et al. | β | 2021 | β |
| Clozapine Management in Schizophrenia Inpatients: A 5-Year Prospective Observational Study of Its Safety and Tolerability Profile. | de Filippis R et al. | β | 2021 | β |
| Differential dopamine release by psychosis-generating and non-psychosis-generating addictive substances in the nucleus accumbens and dorsomedial striatum. | Danielsson K et al. | β | 2021 | β |
| Differential effects of d- and l-enantiomers of govadine on distinct forms of cognitive flexibility and a comparison with dopaminergic drugs. | Dalton GL et al. | β | 2021 | β |
| Drugs Based on NMDAR Hypofunction Hypothesis in Schizophrenia. | Wu Q et al. | β | 2021 | β |
| Early-onset anorexia nervosa with psychotic symptoms: A case report. | Bheemireddy R et al. | β | 2021 | β |
| Effects of JL13, a pyridobenzoxazepine compound, in dopaminergic and glutamatergic models of antipsychotic activity. | Andrade YCP et al. | β | 2021 | β |
| Effects of the co-administration of MK-801 and clozapine on MiRNA expression profiles in rats. | Huang W et al. | β | 2021 | β |
| Enantioenriched Positive Allosteric Modulators Display Distinct Pharmacology at the Dopamine D<sub>1</sub> Receptor. | Fyfe TJ et al. | β | 2021 | β |
| Facial Affect Recognition by Patients with Schizophrenia Using Human Avatars. | Muros NI et al. | β | 2021 | β |
| Frontal GABA in schizophrenia: A meta-analysis of <sup>1</sup>H-MRS studies. | Kumar V et al. | β | 2021 | β |
| Generation of multiple iPSC clones from a male schizophrenia patient carrying de novo mutations in genes KHSRP, LRRC7, and KIR2DL1, and his parents. | Hathy E et al. | β | 2021 | β |
| Generative network models of altered structural brain connectivity in schizophrenia. | Zhang X et al. | β | 2021 | β |
| Global Scientific Outputs of Schizophrenia Publications From 1975 to 2020: a Bibliometric Analysis. | Kiraz S et al. | β | 2021 | β |
| Hearing Voices and Seeing Things: Symptoms of Anxiety Misconstrued as Evidence of Schizophrenia in an Adolescent. | Camerini BA et al. | β | 2021 | β |
| High Risk and Trajectories of Physical Illnesses before the Diagnosis of Bipolar Disorder. | Chen PH et al. | β | 2021 | β |
| Identifying clinical clusters with distinct trajectories in first-episode psychosis through an unsupervised machine learning technique. | Amoretti S et al. | β | 2021 | β |
| Implementing organicity investigations in early psychosis: Spreading expertise. | Kurukgy JL et al. | β | 2021 | β |
| Improving cognition in severe mental illness by combining cognitive remediation and transcranial direct current stimulation: study protocol for a pragmatic randomized controlled pilot trial (HEADDSET). | Poppe A et al. | β | 2021 | β |
| Investigating the association between temperature and hospital admissions for major psychiatric diseases: A study in Greece. | Asimakopoulos LO et al. | β | 2021 | β |
| Ketamine-Induced Alteration of Working Memory Utility during Oculomotor Foraging Task in Monkeys. | Sawagashira R et al. | β | 2021 | β |
| Lower promoter activity of the ST8SIA2 gene has been favored in evolving human collective brains. | Hayakawa T et al. | β | 2021 | β |
| Magnetic resonance imaging in schizophrenia: Luxury or necessity? (Review). | Iliuta FP et al. | β | 2021 | β |
| Maternal immune activation alters the sequential structure of ultrasonic communications in male rats. | Scott KJ et al. | β | 2021 | β |
| Medicinal chemistry strategies for the development of phosphodiesterase 10A (PDE10A) inhibitors - An update of recent progress. | Amin HS et al. | β | 2021 | β |
| Methylation Analysis in Monozygotic Twins With Treatment-Resistant Schizophrenia and Discordant Responses to Clozapine. | Kikuchi M et al. | β | 2021 | β |
| Modeling Neurotransmission: Computational Tools to Investigate Neurological Disorders. | Gandolfi D et al. | β | 2021 | β |
| Neural correlates of emotional processing in psychosis risk and onset - A systematic review and meta-analysis of fMRI studies. | Lukow PB et al. | β | 2021 | β |
| Neural Correlates of Mentalizing in Individuals With Clinical High Risk for Schizophrenia: ALE Meta-Analysis. | Vucurovic K et al. | β | 2021 | β |
| Neurodevelopment regulators miR-137 and miR-34 family as biomarkers for early and adult onset schizophrenia. | Chen BY et al. | β | 2021 | β |
| Obsessive-Compulsive Symptoms and Other Symptoms of the At-risk Mental State for Psychosis: A Network Perspective. | Ong HL et al. | β | 2021 | β |
| Predictors of long-acting injectable antipsychotic treatment discontinuation in outpatients with schizophrenia: relevance of the Drug Attitude Inventory-10. | Tatini L et al. | β | 2021 | β |
| Prefrontal Cortex Development in Health and Disease: Lessons from Rodents and Humans. | Chini M et al. | β | 2021 | β |
| Prospective Long-Term Cohort Study of Subjects With First-Episode Psychosis Examining Eight Major Outcome Domains and Their Predictors: Study Protocol. | Peralta V et al. | β | 2021 | β |
| Proteomics for Target Identification in Psychiatric and Neurodegenerative Disorders. | Antunes ASLM et al. | β | 2021 | β |
| Reduced pain perception in patients with schizophrenia; A missed case of hand fracture. | O'Connell F et al. | β | 2021 | β |
| rTMS Induces Brain Functional and Structural Alternations in Schizophrenia Patient With Auditory Verbal Hallucination. | Xie Y et al. | β | 2021 | β |
| Safety and effectiveness of oral blonanserin for schizophrenia: A review of Japanese post-marketing surveillances. | Inoue Y et al. | β | 2021 | β |
| Safety and related factors of treatment with long-term atypical antipsychotic in Chinese patients with schizophrenia: observational study. | Yu W et al. | β | 2021 | β |
| Salivary cortisol response to psychosocial stress in patients with first-episode psychosis. | Rossini GajΕ‘ak L et al. | β | 2021 | β |
| Schizophrenia risk candidate protein ZNF804A interacts with STAT2 and influences interferon-mediated gene transcription in mammalian cells. | Klockmeier K et al. | β | 2021 | β |
| Serum estradiol as a blood-based biomarker predicting hormonal treatment outcomes in women with schizophrenia. | Thomas N et al. | β | 2021 | β |
| Specialty knowledge and competency standards for pharmacotherapy for adult obsessive-compulsive disorder. | Pittenger C et al. | β | 2021 | β |
| Spinophilin expression in postmortem prefrontal cortex of schizophrenic subjects: Effects of antipsychotic treatment. | Brocos-Mosquera I et al. | β | 2021 | β |
| Stem cell-based models and therapies: a key approach into schizophrenia treatment. | Larijani B et al. | β | 2021 | β |
| Symptomatic Remission Along the Clinical Psychosis Spectrum: A Historical and Conceptual Review. | BΔ±nbay T et al. | β | 2021 | β |
| Systematic epidemiological and clinical comparisons across all 12 DSM-IV psychotic diagnoses in the Cavan-Monaghan First Episode Psychosis Study (CAMFEPS). | Nkire N et al. | β | 2021 | β |
| Targeting Personal Recovery of People With Complex Mental Health Needs: The Development of a Psychosocial Intervention Through User-Centered Design. | van der Meer L et al. | β | 2021 | β |
| The Association between Patient Activation and Outcomes among Severely Mentally Ill Patients. | Forma F et al. | β | 2021 | β |
| The Contribution of Thalamic Nuclei in Salience Processing. | Zhou K et al. | β | 2021 | β |
| The MIR137 VNTR rs58335419 Is Associated With Cognitive Impairment in Schizophrenia and Altered Cortical Morphology. | Mahmoudi E et al. | β | 2021 | β |
| Therapeutic drug monitoring of clozapine in adults with schizophrenia: a review of challenges and strategies. | Molden E | β | 2021 | β |
| Therapeutic role of yoga in neuropsychological disorders. | Nourollahimoghadam E et al. | β | 2021 | β |
| Three-Dimensional Convolutional Autoencoder Extracts Features of Structural Brain Images With a "Diagnostic Label-Free" Approach: Application to Schizophrenia Datasets. | Yamaguchi H et al. | β | 2021 | β |
| TMS-EEG Research to Elucidate the Pathophysiological Neural Bases in Patients with Schizophrenia: A Systematic Review. | Li X et al. | β | 2021 | β |
| Transplantation of mesenchymal stem cells causes long-term alleviation of schizophrenia-like behaviour coupled with increased neurogenesis. | Gobshtis N et al. | β | 2021 | β |
| Twelve-Weeks of Bench-Step Exercise Training Ameliorates Cardiopulmonary Fitness and Mood State in Patients with Schizophrenia: A Pilot Study. | Kuo YC et al. | β | 2021 | β |
| Unique contributions of sensory discrimination and gamma synchronization deficits to cognitive, clinical, and psychosocial functional impairments in schizophrenia. | Koshiyama D et al. | β | 2021 | β |
| Views of Schizophrenia Among Future Healthcare Professionals: Differences in Relation to Diagnostic Labelling, Causal Explanations, and Type of Academic Degree Program. | Sideli L et al. | β | 2021 | β |
| Ξ±7 nicotinic receptor agonist and positive allosteric modulators differently improved schizophrenia-like cognitive deficits in male rats. | Unal G et al. | β | 2021 | β |
| Abnormalities of intrinsic regional brain activity in first-episode and chronic schizophrenia: a meta-analysis of resting-state functional MRI | Gong J et al. | β | 2020 | β |
| Adult Neural Stem Cells as Promising Targets in Psychiatric Disorders. | Rodrigues RS et al. | β | 2020 | β |
| Altered insulin-like growth factor-2 signaling is associated with psychopathology and cognitive deficits in patients with schizophrenia. | Yang YJ et al. | β | 2020 | β |
| A neuroimaging biomarker for striatal dysfunction in schizophrenia. | Li A et al. | β | 2020 | β |
| Annual Prevalence and Incidence of Schizophrenia and Similar Psychotic Disorders in the Republic of Korea: A National Health Insurance Data-Based Study. | Cho SJ et al. | β | 2020 | β |
| Antipsychotic agents deteriorate brain and retinal function in schizophrenia patients with combined auditory and visual hallucinations: A pilot study and secondary follow-up study. | Zhuo C et al. | β | 2020 | β |
| Aripiprazole Cytotoxicity Coincides with Activation of the Unfolded Protein Response in Human Hepatic Cells. | Forno F et al. | β | 2020 | β |
| Asenapine Transdermal Patch for the Management of Schizophrenia. | Zhou M et al. | β | 2020 | β |
| A shared genetic contribution to breast cancer and schizophrenia. | Lu D et al. | β | 2020 | β |
| Association Between Polymorphisms in the 5' Region of the <i>GALR1</i> Gene and Schizophrenia in the Northern Chinese Han Population: A Case-Control Study. | Li Y et al. | β | 2020 | β |
| Association between Serum Essential Metal Elements and the Risk of Schizophrenia in China. | Ma J et al. | β | 2020 | β |
| Associations between schizophrenia polygenic risk and apathy in schizophrenia spectrum disorders and healthy controls. | Lyngstad SH et al. | β | 2020 | β |
| Atypical spatial frequency dependence of visual metacognition among schizophrenia patients. | Koizumi A et al. | β | 2020 | β |
| Binding of clozapine to the GABA<sub>B</sub> receptor: clinical and structural insights. | Nair PC et al. | β | 2020 | β |
| Brain insulin action: Implications for the treatment of schizophrenia. | Agarwal SM et al. | β | 2020 | β |
| Characterization of Clozapine-Responsive Human T Cells. | Ogese MO et al. | β | 2020 | β |
| Childhood adversity and psychosis: a systematic review of bio-psycho-social mediators and moderators. | Sideli L et al. | β | 2020 | β |
| Circular RNAs in Embryogenesis and Cell Differentiation With a Focus on Cancer Development. | Di Agostino S et al. | β | 2020 | β |
| Clozapine: An Updated Overview of Pharmacogenetic Biomarkers, Risks, and Safety-Particularities in the Context of COVID-19. | Dragoi AM et al. | β | 2020 | β |
| Comparing Copper Serum Level and Cognitive Functioning in Patients With Schizophrenia and Healthy Controls. | Mazhari S et al. | β | 2020 | β |
| Crocin alleviates schizophrenia-like symptoms in rats by upregulating silent information regulator-1 and brain derived neurotrophic factor. | Sun XJ et al. | β | 2020 | β |
| Decreased Plasma Levels of Growth Differentiation Factor 11 in Patients With Schizophrenia: Correlation With Psychopathology and Cognition. | Yang ZX et al. | β | 2020 | β |
| Diagnostic and Therapeutic Potential of TSPO Studies Regarding Neurodegenerative Diseases, Psychiatric Disorders, Alcohol Use Disorders, Traumatic Brain Injury, and Stroke: An Update. | Dimitrova-Shumkovska J et al. | β | 2020 | β |
| Discovery and Optimization of Chromone Derivatives as Novel Selective Phosphodiesterase 10 Inhibitors. | Yu YF et al. | β | 2020 | β |
| Dissociation between schizophrenia-relevant behavioral profiles and volumetric brain measures after long-lasting social isolation in Roman rats. | SΓ‘nchez-GonzΓ‘lez A et al. | β | 2020 | β |
| Diverse roles of mtDNA in schizophrenia: Implications in its pathophysiology and as biomarker for cognitive impairment. | SuΓ‘rez-MΓ©ndez S et al. | β | 2020 | β |
| Does genetic mouse model of constitutive Hint1 deficiency exhibit schizophrenia-like behaviors? | Lei G et al. | β | 2020 | β |
| Dopamine, Cognitive Impairments and Second-Generation Antipsychotics: From Mechanistic Advances to More Personalized Treatments. | Torrisi SA et al. | β | 2020 | β |
| Early and very early-onset schizophrenia compared with adult-onset schizophrenia: French FACE-SZ database. | Coulon N et al. | β | 2020 | β |
| Early improvements of individual symptoms as a predictor of treatment response to asenapine in patients with schizophrenia. | Ogyu K et al. | β | 2020 | β |
| Early Signs Monitoring to Prevent Relapse in Psychosis and Promote Well-Being, Engagement, and Recovery: Protocol for a Feasibility Cluster Randomized Controlled Trial Harnessing Mobile Phone Technology Blended With Peer Support. | Gumley A et al. | β | 2020 | β |
| Effect of aerobic exercise combined with cognitive remediation on cortical thickness and prediction of social adaptation in patients with schizophrenia. | Takahashi S et al. | β | 2020 | β |
| Effects of Atypical Antipsychotics on Neuroactive Vitamins in Patients With Schizophrenia. | Yuan T et al. | β | 2020 | β |
| Effects of Mind-Body Exercises on Schizophrenia: A Systematic Review With Meta-Analysis. | Wei GX et al. | β | 2020 | β |
| Effort-related decision making in humanized COMT mice: Effects of Val<sup>158</sup>Met polymorphisms and possible implications for negative symptoms in humans. | Yang JH et al. | β | 2020 | β |
| Face pareidolia in schizophrenia. | Rolf R et al. | β | 2020 | β |
| Factors Moderating the Association Between Cannabis Use and Psychosis Risk: A Systematic Review. | van der Steur SJ et al. | β | 2020 | β |
| Feasibility and Efficacy of a Psychological Therapy for Patients With a Schizophrenic Psychosis in an Inpatient Setting: Study Protocol of a Randomized Switch Controlled Trial. | Redlich Bossy M et al. | β | 2020 | β |
| From apathy to addiction: Insights from neurology and psychiatry. | Kirschner M et al. | β | 2020 | β |
| Genome-wide association study of dietary intake in the UK biobank study and its associations with schizophrenia and other traits. | Niarchou M et al. | β | 2020 | β |
| Glutamatergic Contribution to Probabilistic Reasoning and Jumping to Conclusions in Schizophrenia: A Double-Blind, Randomized Experimental Trial. | Strube W et al. | β | 2020 | β |
| Hyper-Activated Brain Resting-State Network and Mismatch Negativity Deficit in Schizophrenia With Auditory Verbal Hallucination Revealed by an Event-Related Potential Evidence. | Sun Q et al. | β | 2020 | β |
| Identifying signals associated with psychiatric illness utilizing language and images posted to Facebook. | Birnbaum ML et al. | β | 2020 | β |
| Interneuron NMDA Receptor Ablation Induces Hippocampus-Prefrontal Cortex Functional Hypoconnectivity after Adolescence in a Mouse Model of Schizophrenia. | Alvarez RJ et al. | β | 2020 | β |
| Investigation of de novo mutations in a schizophrenia case-parent trio by induced pluripotent stem cell-based in vitro disease modeling: convergence of schizophrenia- and autism-related cellular phenotypes. | Hathy E et al. | β | 2020 | β |
| Latent Clinical-Anatomical Dimensions of Schizophrenia. | Kirschner M et al. | β | 2020 | β |
| Latent Toxoplasmosis Effects on Rodents and Humans: How Much is Real and How Much is Media Hype? | Johnson HJ et al. | β | 2020 | β |
| Lipids as biomarkers of brain disorders. | Hussain G et al. | β | 2020 | β |
| Maternal cerebellar gray matter volume is associated with daughters' psychotic experience. | Hashimoto N et al. | β | 2020 | β |
| Maternal Immune Activation and the Development of Dopaminergic Neurotransmission of the Offspring: Relevance for Schizophrenia and Other Psychoses. | Aguilar-Valles A et al. | β | 2020 | β |
| Metabolomics in Psychiatric Disorders: What We Learn from Animal Models. | Humer E et al. | β | 2020 | β |
| mGluR5 receptor availability is associated with lower levels of negative symptoms and better cognition in male patients with chronic schizophrenia. | RΓ©gio Brambilla C et al. | β | 2020 | β |
| Mimicking of Phase I Metabolism Reactions of Molindone by HLM and Photocatalytic Methods with the Use of UHPLC-MS/MS. | Gawlik M et al. | β | 2020 | β |
| Models Predicting Psychosis in Patients With High Clinical Risk: A Systematic Review. | Montemagni C et al. | β | 2020 | β |
| Modulation of cognition and neuronal plasticity in gain- and loss-of-function mouse models of the schizophrenia risk gene Tcf4. | Badowska DM et al. | β | 2020 | β |
| Neuroimmune Mechanisms and Sex/Gender-Dependent Effects in the Pathophysiology of Mental Disorders. | Kokkosis AG et al. | β | 2020 | β |
| Onset and transition of and recovery from adverse development: Study methodology. | Wigman JTW et al. | β | 2020 | β |
| Persistence of Antipsychotic Use After Clozapine Discontinuation: A Real-World Study Across Antipsychotics. | Stam N et al. | β | 2020 | β |
| Phosphodiesterase inhibitors roflumilast and vardenafil prevent sleep deprivation-induced deficits in spatial pattern separation. | Heckman PRA et al. | β | 2020 | β |
| Prevalence of co-occurring psychiatric disorders in adults and adolescents with intellectual disability: A systematic review and meta-analysis. | Mazza MG et al. | β | 2020 | β |
| Relationship between metabolic syndrome and acylated/desacylated ghrelin ratio in patients with schizophrenia under olanzapine medication. | Wu TH et al. | β | 2020 | β |
| Resveratrol, a SIRT1 Activator, Ameliorates MK-801-Induced Cognitive and Motor Impairments in a Neonatal Rat Model of Schizophrenia. | Niu J et al. | β | 2020 | β |
| Risk Factors of Metabolic Syndrome Among Patients Receiving Antipsychotics: A Retrospective Study. | Hammoudeh S et al. | β | 2020 | β |
| Schizophrenia: Developmental Variability Interacts with Risk Factors to Cause the Disorder: Nonspecific Variability-Enhancing Factors Combine with Specific Risk Factors to Cause Schizophrenia. | Szoke A et al. | β | 2020 | β |
| Schneider's first-rank symptoms as predictors of remission in antipsychotic-naive first-episode psychosis. | Malinowski FR et al. | β | 2020 | β |
| Sexual minority status and symptoms of psychosis: The role of bullying, discrimination, social support, and drug use - Findings from the Adult Psychiatric Morbidity Survey 2007. | Qi R et al. | β | 2020 | β |
| Shorter and longer durations of sleep are associated with an increased twelve-month prevalence of psychiatric and substance use disorders: Findings from a nationally representative survey of US adults (NESARC-III). | Geoffroy PA et al. | β | 2020 | β |
| Sleep spindle and slow wave abnormalities in schizophrenia and other psychotic disorders: Recent findings and future directions. | Zhang Y et al. | β | 2020 | β |
| Specificity and Continuity of Schizophrenia and Bipolar Disorder: Relation to Biomarkers. | Yamada Y et al. | β | 2020 | β |
| Structural Connectivity-Based Parcellation of the Dopaminergic Midbrain in Healthy Subjects and Schizophrenic Patients. | Basile GA et al. | β | 2020 | β |
| The genome-wide risk alleles for psychiatric disorders at 3p21.1 show convergent effects on mRNA expression, cognitive function, and mushroom dendritic spine. | Yang Z et al. | β | 2020 | β |
| The Gut Microbiome in Psychosis From Mice to Men: A Systematic Review of Preclinical and Clinical Studies. | Kraeuter AK et al. | β | 2020 | β |
| The impact of peri-natal stress on psychosis risk: results from the Bo-FEP incidence study. | De Matteis T et al. | β | 2020 | β |
| The Impact of Subsyndromal Bipolar Symptoms on Patient's Functionality and Quality of Life. | Grunze H et al. | β | 2020 | β |
| The P2X7 Receptor: Central Hub of Brain Diseases. | Andrejew R et al. | β | 2020 | β |
| The role of cannabidiol oil in schizophrenia treatment. a systematic review and meta-analysis. | Kopelli E et al. | β | 2020 | β |
| The role of genes affected by human evolution marker GNA13 in schizophrenia. | Xiang B et al. | β | 2020 | β |
| Transcriptome analysis of fibroblasts from schizophrenia patients reveals differential expression of schizophrenia-related genes. | Etemadikhah M et al. | β | 2020 | β |
| Transition of Substance-Induced, Brief, and Atypical Psychoses to Schizophrenia: A Systematic Review and Meta-analysis. | Murrie B et al. | β | 2020 | β |
| Two Novel Loci of <i>RELN</i> Associated With Antipsychotics Response in Chinese Han Population. | Xu Q et al. | β | 2020 | β |
| Validity, Reliability and Clinical Utility of Mental Disorders: The Case of ICD-11 Schizophrenia. | Valle R | β | 2020 | β |
| 2D-DIGE as a strategy to identify serum protein biomarkers to monitor pharmacological efficacy in dopamine-dictated states of Parkinson's disease and schizophrenia. | Gupta AK et al. | β | 2019 | β |
| Acetylsalicylic acid (aspirin) for schizophrenia. | Schmidt L et al. | β | 2019 | β |
| Alterations of Astrocytes in the Context of Schizophrenic Dementia. | Tarasov VV et al. | β | 2019 | β |
| Altered prepulse inhibition of the acoustic startle response in BDNF-deficient mice in a model of early postnatal hypoxia: implications for schizophrenia. | Lima-Ojeda JM et al. | β | 2019 | β |
| A pharmacogenetic study of patients with schizophrenia from West Siberia gets insight into dopaminergic mechanisms of antipsychotic-induced hyperprolactinemia. | Osmanova DZ et al. | β | 2019 | β |
| Aripiprazole Long-Acting Injection During First Episode Schizophrenia-An Exploratory Analysis. | Giordano G et al. | β | 2019 | β |
| Association of Typical Toxic Heavy Metals with Schizophrenia. | Ma J et al. | β | 2019 | β |
| Attentional biases and trauma status: Do psychotic-like experiences matter? | Gibson LE et al. | β | 2019 | β |
| Brexpiprazole: A Review in Schizophrenia. | Frampton JE | β | 2019 | β |
| CDK5: A Unique CDK and Its Multiple Roles in the Nervous System. | CortΓ©s N et al. | β | 2019 | β |
| Childhood trauma- and cannabis-associated microstructural white matter changes in patients with psychotic disorder: a longitudinal family-based diffusion imaging study. | Domen P et al. | β | 2019 | β |
| Chronic clozapine treatment restrains via HDAC2 the performance of mGlu2 receptor agonism in a rodent model of antipsychotic activity. | de la Fuente Revenga M et al. | β | 2019 | β |
| Clinical utility and prospective of TMS-EEG. | Tremblay S et al. | β | 2019 | β |
| Competence to Consent and Its Relationship With Cognitive Function in Patients With Schizophrenia. | Sugawara N et al. | β | 2019 | β |
| Differences Between Self-Reported Psychotic Experiences, Clinically Relevant Psychotic Experiences, and Attenuated Psychotic Symptoms in the General Population. | Moriyama TS et al. | β | 2019 | β |
| Differences in the Effectiveness of Long-Acting Injection and Orally Administered Antipsychotics in Reducing Rehospitalization among Patients with Schizophrenia Receiving Home Care Services. | Hsu HF et al. | β | 2019 | β |
| Differential diagnosis of schizophrenia and schizoaffective disorder from normal subjects using virtual reality. | Kargar M et al. | β | 2019 | β |
| Differential expression of the ghrelin-related mRNAs GHS-R1a, GHS-R1b, and MBOAT4 in Japanese patients with schizophrenia. | Nakata S et al. | β | 2019 | β |
| Digital Technology for Internet Access by Patients With Early-Stage Schizophrenia in Spain: Multicenter Research Study. | FernΓ‘ndez-Sotos P et al. | β | 2019 | β |
| Disturbed Prefrontal Cortex Activity in the Absence of Schizophrenia-Like Behavioral Dysfunction in <i>Arc/Arg3.1</i> Deficient Mice. | Gao X et al. | β | 2019 | β |
| Effect of Adjunctive Estradiol on Schizophrenia Among Women of Childbearing Age: A Randomized Clinical Trial. | Weiser M et al. | β | 2019 | β |
| Effect of discontinuation v. maintenance of antipsychotic medication on relapse rates in patients with remitted/stable first-episode psychosis: a meta-analysis. | Kishi T et al. | β | 2019 | β |
| Effects of olanzapine on cytokine profile and brain-derived neurotrophic factor in drug-naive subjects with first-episode psychosis. | Hatziagelaki E et al. | β | 2019 | β |
| Efficacy and safety of electroacupuncture on metabolic syndrome due to olanzapine and risperidone: Study protocol for a randomized controlled pilot trial. | Ning Y et al. | β | 2019 | β |
| Elevated anti-gliadin IgG antibodies are related to treatment resistance in schizophrenia. | Motoyama M et al. | β | 2019 | β |
| Exposure-lag-response association between sunlight and schizophrenia in Ningbo, China. | Gu S et al. | β | 2019 | β |
| Factors related to malnutrition in community-dwelling patients with schizophrenia. | Kim SR et al. | β | 2019 | β |
| Gender differences among homicide offenders with schizophrenia in Hunan Province, China. | Wang J et al. | β | 2019 | β |
| Generation and Characterization of Induced Pluripotent Stem Cells from Mononuclear Cells in Schizophrenic Patients. | Liu Q et al. | β | 2019 | β |
| Genes in immune pathways associated with abnormal white matter integrity in first-episode and treatment-naΓ―ve patients with schizophrenia. | Xiang B et al. | β | 2019 | β |
| Health Care Resource Utilization and Cost Before Initial Schizophrenia Diagnosis. | Wallace A et al. | β | 2019 | β |
| High prevalence of prediabetes and metabolic abnormalities in overweight or obese schizophrenia patients treated with clozapine or olanzapine. | Larsen JR et al. | β | 2019 | β |
| Histamine H<sub>3</sub> receptor activation reduces the impairment in prepulse inhibition (PPI) of the acoustic startle response and Akt phosphorylation induced by MK-801 (dizocilpine), antagonist at N-Methyl-d-Aspartate (NMDA) receptors. | Aquino-Miranda G et al. | β | 2019 | β |
| Horizontal and vertical integrative analysis methods for mental disorders omics data. | Wang S et al. | β | 2019 | β |
| Hypoactivity of the lateral habenula contributes to negative symptoms and cognitive dysfunction of schizophrenia in rats. | Li J et al. | β | 2019 | β |
| Identity, Subjectivity, and Disorders of Self in Psychosis. | Berkhout SG et al. | β | 2019 | β |
| <i>Drosophila</i> Bruton's Tyrosine Kinase Regulates Habituation Latency and Facilitation in Distinct Mushroom Body Neurons. | Roussou IG et al. | β | 2019 | β |
| Integrated Lipidomics and Proteomics Point to Early Blood-Based Changes in Childhood Preceding Later Development of Psychotic Experiences: Evidence From the Avon Longitudinal Study of Parents and Children. | Madrid-Gambin F et al. | β | 2019 | β |
| Integrative Body-Mind-Spirit (I-BMS) Practices for Schizophrenia: An Outcome Literature Review on Randomized Controlled Trials. | Wang X et al. | β | 2019 | β |
| Interrogating the Evolutionary Paradox of Schizophrenia: A Novel Framework and Evidence Supporting Recent Negative Selection of Schizophrenia Risk Alleles. | Liu C et al. | β | 2019 | β |
| Ketogenic diet for schizophrenia: clinical implication. | Sarnyai Z et al. | β | 2019 | β |
| Ketogenic diet prevents impaired prepulse inhibition of startle in an acute NMDA receptor hypofunction model of schizophrenia. | Kraeuter AK et al. | β | 2019 | β |
| Long-acting atypical antipsychotics in schizophrenia: A systematic review and meta-analyses of effects on functional outcome. | Olagunju AT et al. | β | 2019 | β |
| Machine learning technique reveals intrinsic characteristics of schizophrenia: an alternative method. | Li J et al. | β | 2019 | β |
| Metabolic profiling identifies phospholipids as potential serum biomarkers for schizophrenia. | Wang D et al. | β | 2019 | β |
| Mitochondrial Involvement in Mental Disorders: Energy Metabolism and Genetic and Environmental Factors. | Iwata K | β | 2019 | β |
| Mitochondrial Involvement in Mental Disorders; Energy Metabolism, Genetic, and Environmental Factors. | Iwata K | β | 2019 | β |
| Mortality of site-specific cancer in patients with schizophrenia: a systematic review and meta-analysis. | Ni L et al. | β | 2019 | β |
| Multi-scale analysis of schizophrenia risk genes, brain structure, and clinical symptoms reveals integrative clues for subtyping schizophrenia patients. | Ma L et al. | β | 2019 | β |
| Neurobiology and Therapeutic Potential of Cyclooxygenase-2 (COX-2) Inhibitors for Inflammation in Neuropsychiatric Disorders. | Sethi R et al. | β | 2019 | β |
| Ordered mesoporous carbon-covered carbonized silk fabrics for flexible electrochemical dopamine detection. | Liu X et al. | β | 2019 | β |
| Oxidative Stress and Inflammation in First-Episode Psychosis: A Systematic Review and Meta-analysis. | Fraguas D et al. | β | 2019 | β |
| Psychopathology, cognition and outcome in Dutch and immigrant first-episode psychosis patients. | Stouten LH et al. | β | 2019 | β |
| Quality of Life in Schizophrenia: A Meta-Analysis of Comparative Studies. | Dong M et al. | β | 2019 | β |
| Reconfiguration of Dynamic Functional Connectivity in Sensory and Perceptual System in Schizophrenia. | Dong D et al. | β | 2019 | β |
| Reversal of MK-801-Induced Disruptions in Social Interactions and Working Memory with Simultaneous Administration of LY487379 and VU152100 in Mice. | CieΕlik P et al. | β | 2019 | β |
| Role of basal ganglia neurocircuitry in the pathology of psychiatric disorders. | Macpherson T et al. | β | 2019 | β |
| Role of the endocannabinoid and endovanilloid systems in an animal model of schizophrenia-related emotional processing/cognitive deficit. | Almeida V et al. | β | 2019 | β |
| Schizophrenia risk factors in exceptional achievers: a re-analysis of a 60-year-old database. | SzΓΆke A et al. | β | 2019 | β |
| Serotonin and Glutamate Interactions in Preclinical Schizophrenia Models. | Shah UH et al. | β | 2019 | β |
| Sialic Acids in Neurology. | Sato C et al. | β | 2019 | β |
| Socially Learned Attitude Change is not reduced in Medicated Patients with Schizophrenia. | Simonsen A et al. | β | 2019 | β |
| Staging of Schizophrenia With the Use of PANSS: An International Multi-Center Study. | Fountoulakis KN et al. | β | 2019 | β |
| Suicide-related behaviours in schizophrenia in China: a comprehensive meta-analysis. | Dong M et al. | β | 2019 | β |
| TAK-071, a novel M<sub>1</sub> positive allosteric modulator with low cooperativity, improves cognitive function in rodents with few cholinergic side effects. | Sako Y et al. | β | 2019 | β |
| The Current and Future Potential of Transcranial Magnetic Stimulation With Electroencephalography in Psychiatry. | Hui J et al. | β | 2019 | β |
| The emergence of psychotic experiences in the early adolescence of 22q11.2 Deletion Syndrome. | Chawner SJRA et al. | β | 2019 | β |
| The <i>ANKS1B</i> gene and its associated phenotypes: focus on CNS drug response. | Younis RM et al. | β | 2019 | β |
| The impact of exercise training complementary to early intervention in patients with first-episode psychosis: a qualitative sub-study from a randomized controlled feasibility trial. | Larsen LQ et al. | β | 2019 | β |
| Theory of Mind (ToM) Performance in High Functioning Autism (HFA) and Schizotypal-Schizoid Personality Disorders (SSPD) Patients. | Booules-Katri TM et al. | β | 2019 | β |
| The relationship between childhood trauma, dopamine release and dexamphetamine-induced positive psychotic symptoms: a [<sup>11</sup>C]-(+)-PHNO PET study. | Dahoun T et al. | β | 2019 | β |
| The Schizophrenia Susceptibility Gene OPCML Regulates Spine Maturation and Cognitive Behaviors through Eph-Cofilin Signaling. | Zhang Z et al. | β | 2019 | β |
| The Therapeutic Potential of Ketogenic Diet Throughout Life: Focus on Metabolic, Neurodevelopmental and Neurodegenerative Disorders. | Kraeuter AK et al. | β | 2019 | β |
| Transdiagnostic dimensions of psychopathology at first episode psychosis: findings from the multinational EU-GEI study. | Quattrone D et al. | β | 2019 | β |
| Transdiagnostic dimensions of psychosis in the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP). | Reininghaus U et al. | β | 2019 | β |
| Transient Knock-Down of Prefrontal DISC1 in Immune-Challenged Mice Causes Abnormal Long-Range Coupling and Cognitive Dysfunction throughout Development. | Xu X et al. | β | 2019 | β |
| Two Sides of the Same Coin: A Case Report of First-Episode Catatonic Syndrome in a High-Functioning Autism Patient. | Hefter D et al. | β | 2019 | β |
| Using Google Maps to display the pattern of coauthor collaborations on the topic of schizophrenia: A systematic review between 1937 and 2017. | Chien TW et al. | β | 2019 | β |
| Using human stem cells as a model system to understand the neural mechanisms of alcohol use disorders: Current status and outlook. | Scarnati MS et al. | β | 2019 | β |
| Using Twitter to assess attitudes to schizophrenia and psychosis. | Passerello GL et al. | β | 2019 | β |
| Validation and refinement of the clinical staging model in a French cohort of outpatient with schizophrenia (FACE-SZ). | Godin O et al. | β | 2019 | β |
| Yoga as part of a package of care versus non-standard care for schizophrenia. | Broderick J et al. | β | 2019 | β |
| "You have to believe in something": Risk of psychosis and psychiatrists' beliefs in the self-fulfilling prophecy. | Benoit L et al. | β | 2019 | β |
| A biopsychosocial evaluation of the risk for suicide in schizophrenia. | Hettige NC et al. | β | 2018 | β |
| A comparative study of the typical toxic metals in serum by patients of schizophrenia and healthy controls in China. | Ma J et al. | β | 2018 | β |
| Acupuncture as Add-On Treatment of the Positive, Negative, and Cognitive Symptoms of Patients with Schizophrenia: A Systematic Review. | van den Noort M et al. | β | 2018 | β |
| A dimensional approach to assessing psychiatric risk in adults born very preterm. | Kroll J et al. | β | 2018 | β |
| A kernel machine method for detecting higher order interactions in multimodal datasets: Application to schizophrenia. | Alam MA et al. | β | 2018 | β |
| Alterations of eicosanoids and related mediators in patients with schizophrenia. | Wang D et al. | β | 2018 | β |
| Altered Expression Profile of IgLON Family of Neural Cell Adhesion Molecules in the Dorsolateral Prefrontal Cortex of Schizophrenic Patients. | Karis K et al. | β | 2018 | β |
| A molecule-based genetic association approach implicates a range of voltage-gated calcium channels associated with schizophrenia. | Li W et al. | β | 2018 | β |
| Analysis of the concentrations and size distributions of cell-free DNA in schizophrenia using fluorescence correlation spectroscopy. | Jiang J et al. | β | 2018 | β |
| Anti-Dementia Drugs for Psychopathology and Cognitive Impairment in Schizophrenia: A Systematic Review and Meta-Analysis. | Kishi T et al. | β | 2018 | β |
| An Update on Promising Biomarkers in Schizophrenia. | Goldsmith DR et al. | β | 2018 | β |
| A Population Pharmacokinetic and Pharmacodynamic Analysis of RP5063 Phase 2 Study Data in Patients with Schizophrenia or Schizoaffective Disorder. | Cantillon M et al. | β | 2018 | β |
| Are structural brain changes in schizophrenia related to antipsychotic medication? A narrative review of the evidence from a clinical perspective. | Lawrie SM | β | 2018 | β |
| Association between celiac disease and schizophrenia: a meta-analysis. | Wijarnpreecha K et al. | β | 2018 | β |
| Association between genetic variability of neuronal nitric oxide synthase and sensorimotor gating in humans. | RovnΓ½ R et al. | β | 2018 | β |
| Association of Schizotypy With Dimensions of Cognitive Control: A Meta-Analysis. | Steffens M et al. | β | 2018 | β |
| Brain, blood, cerebrospinal fluid, and serum biomarkers in schizophrenia. | Mohammadi A et al. | β | 2018 | β |
| Calcium as a Trojan horse in mental diseases-The role of PMCA and PMCA-interacting proteins in bipolar disorder and schizophrenia. | Lisek M et al. | β | 2018 | β |
| Cardiovascular Risk in Early Psychosis: Relationship with Inflammation and Clinical Features 6 Months after Diagnosis. | Barcones MF et al. | β | 2018 | β |
| Cell-subtype-specific changes in adenosine pathways in schizophrenia. | O'Donovan SM et al. | β | 2018 | β |
| Change in Prolactin Levels in Pediatric Patients Given Antipsychotics for Schizophrenia and Schizophrenia Spectrum Disorders: A Network Meta-Analysis. | Balijepalli C et al. | β | 2018 | β |
| Classics in Chemical Neuroscience: Risperidone. | Chopko TC et al. | β | 2018 | β |
| Clozapine attenuates mitochondrial burdens and abnormal behaviors elicited by phencyclidine in mice via inhibition of p47 <sup>phox</sup>; Possible involvements of phosphoinositide 3-kinase/Akt signaling. | Tran HQ et al. | β | 2018 | β |
| Cognitive Behavioural Therapy for Psychosis: A Health Technology Assessment. | Health Quality Ontario | β | 2018 | β |
| Cognitive Function and Monoamine Neurotransmission in Schizophrenia: Evidence From Positron Emission Tomography Studies. | Takano H | β | 2018 | β |
| Comparison of the effectiveness of brand-name and generic antipsychotic drugs for treating patients with schizophrenia in Taiwan. | Hsu CW et al. | β | 2018 | β |
| [Cost analyses of medical care for schizophrenia and depression in MΓ©xico, 2005-2013]. | Arredondo A et al. | β | 2018 | β |
| Course of Cognitive Development From Infancy to Early Adulthood in the Psychosis Spectrum. | Mollon J et al. | β | 2018 | β |
| Curcumin loading potentiates the neuroprotective efficacy of Fe<sub>3</sub>O<sub>4</sub> magnetic nanoparticles in cerebellum cells of schizophrenic rats. | Naserzadeh P et al. | β | 2018 | β |
| Decreased IL-1ra and NCAM-1/CD56 Serum Levels in Unmedicated Patients with Schizophrenia Before and After Antipsychotic Treatment. | Chu CS et al. | β | 2018 | β |
| Detecting allocentric and egocentric navigation deficits in patients with schizophrenia and bipolar disorder using virtual reality. | Mohammadi A et al. | β | 2018 | β |
| DNA methylation and antipsychotic treatment mechanisms in schizophrenia: Progress and future directions. | Ovenden ES et al. | β | 2018 | β |
| Do clinical characteristics predict the cognitive course in early-onset schizophrenia-spectrum disorders? | Teigset CM et al. | β | 2018 | β |
| Dopamine perturbation of gene co-expression networks reveals differential response in schizophrenia for translational machinery. | Kos MZ et al. | β | 2018 | β |
| Early human brain development: Starring the subplate. | Hadders-Algra M | β | 2018 | β |
| Effects of genetic and environmental risk for schizophrenia on hippocampal activity and psychosis-like behavior in mice. | Scott D et al. | β | 2018 | β |
| Effects of ketamine on brain function during response inhibition. | Steffens M et al. | β | 2018 | β |
| Effects of the monoamine stabilizer (-)-OSU6162 on locomotor and sensorimotor responses predictive of antipsychotic activity. | da Silveira VT et al. | β | 2018 | β |
| Efficacy and metabolic effects of lurasidone versus brexpiprazole in schizophrenia: a network meta-analysis. | Ng-Mak D et al. | β | 2018 | β |
| Emerging and evolving concepts in the pathobiology and treatment of psychosis. | Zhen XC et al. | β | 2018 | β |
| Emotion and self in psychotic disorders: Behavioral evidence from an emotional evaluation task using verbal stimuli varying in emotional valence and self-reference. | Herbert C et al. | β | 2018 | β |
| Epidemiology of Suicide and the Psychiatric Perspective. | Bachmann S | β | 2018 | β |
| ErbB signaling antagonist ameliorates behavioral deficit induced by phencyclidine (PCP) in mice, without affecting metabolic syndrome markers. | Tadmor H et al. | β | 2018 | β |
| Evaluation of the Effect of Fluvoxamine in Patients With Schizophrenia Under Risperidone Treatment: A Clinical Trial. | Haji Seyed Javadi A et al. | β | 2018 | β |
| Folic acid/methylfolate for the treatment of psychopathology in schizophrenia: a systematic review and meta-analysis. | Sakuma K et al. | β | 2018 | β |
| Functional outcome and service engagement in major depressive disorder with psychotic features: comparisons with schizophrenia, schizoaffective disorder and bipolar disorder in a 6-year follow-up of the Cavan-Monaghan First Episode Psychosis Study (CAMFEPS). | Kingston T et al. | β | 2018 | β |
| Gender-specific risk factors for low bone mineral density in patients taking antipsychotics for psychosis. | Jhon M et al. | β | 2018 | β |
| Genetic and clinical features of social cognition in 22q11.2 deletion syndrome. | Lattanzi GM et al. | β | 2018 | β |
| Genetic risk between the <i>CACNA1I</i> gene and schizophrenia in Chinese Uygur population. | Xu W et al. | β | 2018 | β |
| Genome-wide Association Analysis of Eye Movement Dysfunction in Schizophrenia. | Kikuchi M et al. | β | 2018 | β |
| Gray and white matter changes and their relation to illness trajectory in first episode psychosis. | Keymer-Gausset A et al. | β | 2018 | β |
| Haplotypes of TNF<i>Ξ±</i>/<i>Ξ²</i> Genes Associated with Sex-Specific Paranoid Schizophrenic Risk in Tunisian Population. | Inoubli O et al. | β | 2018 | β |
| HDAC2-dependent Antipsychotic-like Effects of Chronic Treatment with the HDAC Inhibitor SAHA in Mice. | de la Fuente Revenga M et al. | β | 2018 | β |
| Health service utilization and medical costs among patients with schizophrenia receiving long-acting injectable risperidone versus oral risperidone: a nationwide retrospective matched cohort study in Taiwan. | Fan SJ et al. | β | 2018 | β |
| Higher schizotypy predicts better metabolic profile in unaffected siblings of patients with schizophrenia. | Atbasoglu EC et al. | β | 2018 | β |
| Hospitalization outcomes in patients with schizophrenia after switching to lurasidone or quetiapine: a US claims database analysis. | Newcomer JW et al. | β | 2018 | β |
| Increased resting-state global functional connectivity density of default mode network in schizophrenia subjects treated with electroconvulsive therapy. | Huang H et al. | β | 2018 | β |
| Inhibitory control of the excitatory/inhibitory balance in psychiatric disorders. | Selten M et al. | β | 2018 | β |
| Initial Clinical Experience of RP5063 Following Single Doses in Normal Healthy Volunteers and Multiple Doses in Patients with Stable Schizophrenia. | Cantillon M et al. | β | 2018 | β |
| <i>VRK2</i>, a Candidate Gene for Psychiatric and Neurological Disorders. | Li M et al. | β | 2018 | β |
| Ketamine Alters Lateral Prefrontal Oscillations in a Rule-Based Working Memory Task. | Ma L et al. | β | 2018 | β |
| Leptin/Adiponectin ratio as a potential biomarker for metabolic syndrome in patients with schizophrenia. | Chen VC et al. | β | 2018 | β |
| Literature review and economic evaluation of oral and intramuscular ziprasidone treatment among patients with schizophrenia in China. | Yeh YC et al. | β | 2018 | β |
| Long-Term Antipsychotic Effectiveness in First Episode of Psychosis: A 3-Year Follow-Up Randomized Clinical Trial Comparing Aripiprazole, Quetiapine, and Ziprasidone. | GΓ³mez-Revuelta M et al. | β | 2018 | β |
| Management of depression in patients with schizophrenia spectrum disorders: a critical review of international guidelines. | DondΓ© C et al. | β | 2018 | β |
| Mass spectrometry identification of potential biomarker proteins in the 150-kD electrophoretic band in patients with schizophrenia. | Xu R et al. | β | 2018 | β |
| Maternal personality disorder symptoms in primary health care: associations with mother-toddler interactions at one-year follow-up. | HΓΈivik MS et al. | β | 2018 | β |
| Metabotropic glutamate receptor modulation of dopamine release in the nucleus accumbens shell is unaffected by phencyclidine pretreatment: In vitro assessment using fast-scan cyclic voltammetry rat brain slices. | Gupta I et al. | β | 2018 | β |
| MiRNAs of peripheral blood as the biomarker of schizophrenia. | He K et al. | β | 2018 | β |
| Modelling the neuromotor abnormalities of psychotic illness: Putative mechanisms and systems dysfunction. | Waddington JL et al. | β | 2018 | β |
| Modification of the association between antipsychotic treatment response and childhood adversity by MMP9 gene variants in a first-episode schizophrenia cohort. | McGregor N et al. | β | 2018 | β |
| Natural Medicines for Psychotic Disorders: A Systematic Review. | Hoenders HJR et al. | β | 2018 | β |
| Neural correlates of exercise training in individuals with schizophrenia and in healthy individuals: A systematic review. | van der Stouwe ECD et al. | β | 2018 | β |
| Non-coding RNA dysregulation in the amygdala region of schizophrenia patients contributes to the pathogenesis of the disease. | Liu Y et al. | β | 2018 | β |
| Overlapping and disease specific trait, response, and reflection impulsivity in adolescents with first-episode schizophrenia spectrum disorders or attention-deficit/hyperactivity disorder. | Jepsen JRM et al. | β | 2018 | β |
| Perinatal Hypoxia and Ischemia in Animal Models of Schizophrenia. | Hefter D et al. | β | 2018 | β |
| Pharmacokinetics of RP5063 Following Single Doses to Normal Healthy Volunteers and Multiple Doses Over 10 Days to Stable Schizophrenic Patients. | Cantillon M et al. | β | 2018 | β |
| Phosphodiesterase inhibition and modulation of corticostriatal and hippocampal circuits: Clinical overview and translational considerations. | Heckman PRA et al. | β | 2018 | β |
| [Physical activity in patients with schizophrenia: From neurobiology to clinical benefits]. | TrΓ©hout M et al. | β | 2018 | β |
| Predictors of negative symptoms in the chronic phase of schizophrenia: A cross-sectional study. | Fujimaki K et al. | β | 2018 | β |
| Prenatal exposure to ketamine in rats: Implications on animal models of schizophrenia. | Coronel-Oliveros CM et al. | β | 2018 | β |
| Prevalence of Comorbid Chronic Obstructive Pulmonary Disease in Individuals Suffering from Schizophrenia and Bipolar Disorder: A Systematic Review. | Zareifopoulos N et al. | β | 2018 | β |
| Projecting the Potential Effect of Using Paliperidone Palmitate Once-Monthly and Once-Every-3-Months Long-Acting Injections Among Medicaid Beneficiaries with Schizophrenia. | Basu A et al. | β | 2018 | β |
| Prolactin and Thyroid Stimulating Hormone (TSH) Levels and Sexual Dysfunction in Patients with Schizophrenia Treated with Conventional Antipsychotic Medication: A Cross-Sectional Study. | Zhang Y et al. | β | 2018 | β |
| Proteomic Studies of Psychiatric Disorders. | Guest PC | β | 2018 | β |
| Purinergic system in psychiatric diseases. | Cheffer A et al. | β | 2018 | β |
| Quality of life in Chinese patients with schizophrenia: A meta-analysis. | Lu L et al. | β | 2018 | β |
| Recognition of Schizophrenia with Regularized Support Vector Machine and Sequential Region of Interest Selection using Structural Magnetic Resonance Imaging. | Chin R et al. | β | 2018 | β |
| Regulation of inflammatory pathways in schizophrenia: A comparative study with bipolar disorder and healthy controls. | GarcΓa-Γlvarez L et al. | β | 2018 | β |
| Relationship between incidence and prevalence in psychotic disorders: An incidence-prevalence-mortality model. | Pignon B et al. | β | 2018 | β |
| Risk of pleural empyema in patients with schizophrenia: a nationwide propensity-matched cohort study in Taiwan. | Shen TC et al. | β | 2018 | β |
| Role of frontal white matter and corpus callosum on social function in schizophrenia. | Koshiyama D et al. | β | 2018 | β |
| Schizophrenia: synthetic strategies and recent advances in drug design. | Azmanova M et al. | β | 2018 | β |
| Sibship size, birth order and psychotic experiences: Evidence from 43 low- and middle-income countries. | Koyanagi A et al. | β | 2018 | β |
| Side effect burden of antipsychotic drugs in real life - Impact of gender and polypharmacy. | Iversen TSJ et al. | β | 2018 | β |
| Social Cognition in Schizophrenia: Cognitive and Neurobiological Aspects. | GarcΓa RR et al. | β | 2018 | β |
| Specialized psychiatric services: patient characteristics, referral practice and length of stay in a representative clinical sample 2010-2016. | Bakken TL et al. | β | 2018 | β |
| Statin add-on therapy in the antipsychotic treatment of schizophrenia: A meta-analysis. | Nomura I et al. | β | 2018 | β |
| Structural and functional brain abnormalities in schizophrenia: A cross-sectional study at different stages of the disease. | Zhao C et al. | β | 2018 | β |
| Studying and modulating schizophrenia-associated dysfunctions of oligodendrocytes with patient-specific cell systems. | Raabe FJ et al. | β | 2018 | β |
| Study protocol for a prospective cohort study examining the predictive potential of dynamic symptom networks for the onset and progression of psychosis: the Mapping Individual Routes of Risk and Resilience (Mirorr) study. | Booij SH et al. | β | 2018 | β |
| Synaptic NMDA Receptor Activation Induces Ubiquitination and Degradation of STEP<sub>61</sub>. | Xu J et al. | β | 2018 | β |
| TAK-063, a novel PDE10A inhibitor with balanced activation of direct and indirect pathways, provides a unique opportunity for the treatment of schizophrenia. | Suzuki K et al. | β | 2018 | β |
| Temperament in child and adolescent offspring of patients with schizophrenia and bipolar disorder. | DΓaz-Caneja CM et al. | β | 2018 | β |
| The association between neonatal vitamin D status and risk of schizophrenia. | Eyles DW et al. | β | 2018 | β |
| The central serotonin<sub>2B</sub> receptor as a new pharmacological target for the treatment of dopamine-related neuropsychiatric disorders: Rationale and current status of research. | Devroye C et al. | β | 2018 | β |
| The C'JAAD: a French team for early intervention in psychosis in Paris. | Oppetit A et al. | β | 2018 | β |
| The link between schizophrenia and hypothyroidism: a population-based study. | Sharif K et al. | β | 2018 | β |
| The Long Noncoding RNA Landscape in Amygdala Tissues from Schizophrenia Patients. | Tian T et al. | β | 2018 | β |
| The relationship between quality of life and physical fitness in people with severe mental illness. | Perez-Cruzado D et al. | β | 2018 | β |
| The replacement of assertive outreach services by reinforcing local community teams: a four-year observational study. | Firn M et al. | β | 2018 | β |
| The Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations, Outcomes (REACH-OUT) study: real-world clinical practice in schizophrenia. | Joshi K et al. | β | 2018 | β |
| Utilising symptom dimensions with diagnostic categories improves prediction of time to first remission in first-episode psychosis. | Ajnakina O et al. | β | 2018 | β |
| Ventral Striatal Dysfunction and Symptom Expression in Individuals With Schizotypal Personality Traits and Early Psychosis. | Kirschner M et al. | β | 2018 | β |
| 5-HT6 Receptor Antagonist as an Adjunct Treatment Targeting Residual Symptoms in Patients With Schizophrenia: Unexpected Sex-Related Effects (Double-Blind Placebo-Controlled Trial). | Morozova M et al. | β | 2017 | β |
| Abnormalities of Dopamine D<sub>3</sub> Receptor Signaling in the Diseased Brain. | Prieto GA | β | 2017 | β |
| Accumulation of minor alleles and risk prediction in schizophrenia. | He P et al. | β | 2017 | β |
| A current view on contactin-4, -5, and -6: Implications in neurodevelopmental disorders. | Oguro-Ando A et al. | β | 2017 | β |
| Acute Antipsychotic Treatment of Children and Adolescents With Schizophrenia-Spectrum Disorders: A Systematic Review and Network Meta-Analysis. | Pagsberg AK et al. | β | 2017 | β |
| Adequate clinical practice limited by the ethnic French taboo. | Guerrier G et al. | β | 2017 | β |
| An emerging role for mitochondrial dynamics in schizophrenia. | Flippo KH et al. | β | 2017 | β |
| A Network Approach to Psychosis: Pathways Between Childhood Trauma and Psychotic Symptoms. | Isvoranu AM et al. | β | 2017 | β |
| A Novel Bio-Psychosocial-Behavioral Treatment Model in Schizophrenia. | Kim YK et al. | β | 2017 | β |
| Antipsychotic-induced Hdac2 transcription via NF-ΞΊB leads to synaptic and cognitive side effects. | Ibi D et al. | β | 2017 | β |
| Are reprogrammed cells a useful tool for studying dopamine dysfunction in psychotic disorders? A review of the current evidence. | Sauerzopf U et al. | β | 2017 | β |
| Assessment of the consequences of caregiving in psychosis: a psychometric comparison of the Zarit Burden Interview (ZBI) and the Involvement Evaluation Questionnaire (IEQ). | GonΓ§alves-Pereira M et al. | β | 2017 | β |
| Association between alcohol, cannabis, and other illicit substance abuse and risk of developing schizophrenia: a nationwide population based register study. | Nielsen SM et al. | β | 2017 | β |
| Associations between neurodevelopmental genes, neuroanatomy, and ultra high risk symptoms of psychosis in 22q11.2 deletion syndrome. | Thompson CA et al. | β | 2017 | β |
| Autistic and schizotypal traits and global functioning in bipolar I disorder. | Abu-Akel A et al. | β | 2017 | β |
| BACE1-Dependent Neuregulin-1 Signaling: An Implication for Schizophrenia. | Zhang Z et al. | β | 2017 | β |
| Brain neurodevelopmental markers related to the deficit subtype of schizophrenia. | Takahashi T et al. | β | 2017 | β |
| Brain-Specific SNAP-25 Deletion Leads to Elevated Extracellular Glutamate Level and Schizophrenia-Like Behavior in Mice. | Yang H et al. | β | 2017 | β |
| Burden of illness of people with persistent symptoms of schizophrenia: A multinational cross-sectional study. | Nordstroem AL et al. | β | 2017 | β |
| Burnout in early course psychosis caregivers: the role of illness beliefs and coping styles. | Onwumere J et al. | β | 2017 | β |
| Chlorpromazine Increases the Expression of Polysialic Acid (PolySia) in Human Neuroblastoma Cells and Mouse Prefrontal Cortex. | Abe C et al. | β | 2017 | β |
| Clozapine dose for schizophrenia. | Subramanian S et al. | β | 2017 | β |
| Cognitive effects of adjunctive N-acetyl cysteine in psychosis. | Rapado-Castro M et al. | β | 2017 | β |
| Comparative study on serum levels of macro and trace elements in schizophrenia based on supervised learning methods. | Lin T et al. | β | 2017 | β |
| Comparison of Nanoemulsion and Aqueous Micelle Systems of Paliperidone for Intranasal Delivery. | Pidaparthi K et al. | β | 2017 | β |
| Comprehensive review: Computational modelling of schizophrenia. | Valton V et al. | β | 2017 | β |
| Connecting Biology to Electronics: Molecular Communication via Redox Modality. | Liu Y et al. | β | 2017 | β |
| Consistent Functional Connectivity Alterations in Schizophrenia Spectrum Disorder: A Multisite Study. | SkΓ₯tun KC et al. | β | 2017 | β |
| Development of a UPLC-MS/MS method for routine therapeutic drug monitoring of aripiprazole, amisulpride, olanzapine, paliperidone and ziprasidone with a discussion of their therapeutic reference ranges for Chinese patients. | Wang ST et al. | β | 2017 | β |
| Distinct multivariate brain morphological patterns and their added predictive value with cognitive and polygenic risk scores in mental disorders. | Doan NT et al. | β | 2017 | β |
| Distinct Patterns of Cerebral Cortical Thinning in Schizophrenia: A Neuroimaging Data-Driven Approach. | Sugihara G et al. | β | 2017 | β |
| DNA Methylation in Schizophrenia. | Pries LK et al. | β | 2017 | β |
| Do paranoid delusions exist on a continuum with subclinical paranoia? A multi-method taxometric study. | Elahi A et al. | β | 2017 | β |
| Effect of an art brut therapy program called go beyond the schizophrenia (GBTS) on prison inmates with schizophrenia in mainland China-A randomized, longitudinal, and controlled trial. | Qiu HZ et al. | β | 2017 | β |
| Effects of early or late prenatal immune activation in mice on behavioral and neuroanatomical abnormalities relevant to schizophrenia in the adulthood. | da Silveira VT et al. | β | 2017 | β |
| Efficacy, acceptability and tolerability of 8 atypical antipsychotics in Chinese patients with acute schizophrenia: A network meta-analysis. | Bai Z et al. | β | 2017 | β |
| Efficacy of Risperidone Augmentation with Ondansetron in the Treatment of Negative and Depressive Symptoms in Schizophrenia: A Randomized Clinical Trial. | Samadi R et al. | β | 2017 | β |
| Establishment of a schizophrenic animal model through chronic administration of MK-801 in infancy and social isolation in childhood. | Liu W et al. | β | 2017 | β |
| Exome sequences of multiplex, multigenerational families reveal schizophrenia risk loci with potential implications for neurocognitive performance. | Kos MZ et al. | β | 2017 | β |
| Experimental evidence for circular inference in schizophrenia. | Jardri R et al. | β | 2017 | β |
| Factors associated with expression of extrapyramidal symptoms in users of atypical antipsychotics. | Ribeiro SB et al. | β | 2017 | β |
| Gender-Specific Associations between CHGB Genetic Variants and Schizophrenia in a Korean Population. | Shin JG et al. | β | 2017 | β |
| Genetic evidence for role of integration of fast and slow neurotransmission in schizophrenia. | Devor A et al. | β | 2017 | β |
| Genetic loci associated with an earlier age at onset in multiplex schizophrenia. | Woolston AL et al. | β | 2017 | β |
| Genetic variation in the 3'-untranslated region of <i>PAK1</i> influences schizophrenia susceptibility. | Jiang J et al. | β | 2017 | β |
| Haloperidol affects bones while clozapine alters metabolic parameters - sex specific effects in rats perinatally treated with phencyclidine. | NikoliΔ T et al. | β | 2017 | β |
| Health care resource utilization and costs of California Medicaid patients with schizophrenia treated with paliperidone palmitate once monthly or atypical oral antipsychotic treatment. | Pesa JA et al. | β | 2017 | β |
| High serum soluble tumor necrosis factor receptor 1 predicts poor treatment response in acute-stage schizophrenia. | Nishimon S et al. | β | 2017 | β |
| HINT1 in Neuropsychiatric Diseases: A Potential Neuroplastic Mediator. | Liu P et al. | β | 2017 | β |
| Hippocampal GABAergic Inhibitory Interneurons. | Pelkey KA et al. | β | 2017 | β |
| Identification of a plasma signature of psychotic disorder in children and adolescents from the Avon Longitudinal Study of Parents and Children (ALSPAC) cohort. | O'Gorman A et al. | β | 2017 | β |
| Identification of Gene Loci That Overlap Between Schizophrenia and Educational Attainment. | Le Hellard S et al. | β | 2017 | β |
| Impaired Latent Inhibition in GDNF-Deficient Mice Exposed to Chronic Stress. | Buhusi M et al. | β | 2017 | β |
| Juvenile treatment with a novel mGluR2 agonist/mGluR3 antagonist compound, LY395756, reverses learning deficits and cognitive flexibility impairments in adults in a neurodevelopmental model of schizophrenia. | Li ML et al. | β | 2017 | β |
| Language deficits in schizophrenia and autism as related oscillatory connectomopathies: An evolutionary account. | Murphy E et al. | β | 2017 | β |
| Listening to Sentences in Noise: Revealing Binaural Hearing Challenges in Patients with Schizophrenia. | Abdul Wahab NA et al. | β | 2017 | β |
| Local and Widely Distributed EEG Activity in Schizophrenia With Prevalence of Negative Symptoms. | Grin-Yatsenko VA et al. | β | 2017 | β |
| Longitudinal study of premorbid adjustment in 22q11.2 deletion (velocardiofacial) syndrome and association with psychosis. | Radoeva PD et al. | β | 2017 | β |
| Making Sense of: Sensitization in Schizophrenia. | Weidenauer A et al. | β | 2017 | β |
| Mapping the evidence on pharmacological interventions for non-affective psychosis in humanitarian non-specialised settings: a UNHCR clinical guidance. | Ostuzzi G et al. | β | 2017 | β |
| Memantine add-on to antipsychotic treatment for residual negative and cognitive symptoms of schizophrenia: a meta-analysis. | Kishi T et al. | β | 2017 | β |
| Metyrosine treatment in a woman with chromosome 22q11.2 deletion syndrome and psychosis: a case study. | Engebretsen MH et al. | β | 2017 | β |
| Microglia Gone Rogue: Impacts on Psychiatric Disorders across the Lifespan. | Tay TL et al. | β | 2017 | β |
| Mild Depressive Symptoms Mediate the Impact of Childhood Trauma on Long-Term Functional Outcome in Early Psychosis Patients. | Alameda L et al. | β | 2017 | β |
| MiR-137: an important player in neural development and neoplastic transformation. | Mahmoudi E et al. | β | 2017 | β |
| Molecular Mechanism and Dynamics of <i>S</i>-Deoxyephedrine Moving through Molecular Channels within D<sub>3</sub>R. | Li AJ et al. | β | 2017 | β |
| More than 25 years of genetic studies of clozapine-induced agranulocytosis. | de With SAJ et al. | β | 2017 | β |
| Neural - hormonal responses to negative affective stimuli: Impact of dysphoric mood and sex. | Mareckova K et al. | β | 2017 | β |
| Neuroadaptations to antipsychotic drugs: Insights from pre-clinical and human post-mortem studies. | Amato D et al. | β | 2017 | β |
| Neuroimmune Interactions in Schizophrenia: Focus on Vagus Nerve Stimulation and Activation of the Alpha-7 Nicotinic Acetylcholine Receptor. | Corsi-Zuelli FMDG et al. | β | 2017 | β |
| Occupation and first episode psychosis in Northern Italy: better outcomes for migrants. | Tarricone I et al. | β | 2017 | β |
| Omega-3 fatty acids related to cognitive impairment in patients with schizophrenia. | Satogami K et al. | β | 2017 | β |
| On the integrity of functional brain networks in schizophrenia, Parkinson's disease, and advanced age: Evidence from connectivity-based single-subject classification. | PlΓ€schke RN et al. | β | 2017 | β |
| Parvalbumin-containing GABA cells and schizophrenia: experimental model based on targeted gene delivery through adeno-associated viruses. | Woloszynowska-Fraser MU et al. | β | 2017 | β |
| Pluripotent stem cells in neuropsychiatric disorders. | Soliman MA et al. | β | 2017 | β |
| Profiling of Acylcarnitines in First Episode Psychosis before and after Antipsychotic Treatment. | Kriisa K et al. | β | 2017 | β |
| Progressive disability and prefrontal shrinkage in schizophrenia patients with poor outcome: A 3-year longitudinal study. | Dusi N et al. | β | 2017 | β |
| Psychopathological and demographic characteristics of hallucinating patients with schizophrenia and schizoaffective disorder: an analysis based on AMDP data. | Baethge C et al. | β | 2017 | β |
| Quality of care indicators for schizophrenia: determinants of observed variations among Italian Departments of Mental Health. Results from the ETAS DSM study. | Fantini G et al. | β | 2017 | β |
| Redox Probing for Chemical Information of Oxidative Stress. | Kim E et al. | β | 2017 | β |
| Relationships between serum brain-derived neurotrophic factor, plasma catecholamine metabolites, cytokines, cognitive function and clinical symptoms in Japanese patients with chronic schizophrenia treated with atypical antipsychotic monotherapy. | Hori H et al. | β | 2017 | β |
| Reversal of olanzapine-induced weight gain in a patient with schizophrenia by switching to asenapine: a case report. | Okazaki K et al. | β | 2017 | β |
| Sensory integration deficits support a dimensional view of psychosis and are not limited to schizophrenia. | Carter O et al. | β | 2017 | β |
| Serum levels of second-generation antipsychotics are associated with cognitive function in psychotic disorders. | Steen NE et al. | β | 2017 | β |
| Single- and Multiple-Dose Pharmacokinetics, Safety and Tolerability of Lurasidone in Healthy Chinese Subjects. | Hu C et al. | β | 2017 | β |
| Striatal phosphodiesterase 10A and medial prefrontal cortical thickness in patients with schizophrenia: a PET and MRI study. | BodΓ©n R et al. | β | 2017 | β |
| Sun Exposure and Psychotic Experiences. | Pilecka I et al. | β | 2017 | β |
| Surgical Management of Obesity Among People with Schizophrenia and Bipolar Disorder: a Systematic Review of Outcomes and Recommendations for Future Research. | Kouidrat Y et al. | β | 2017 | β |
| Targeting metabotropic glutamate receptors for novel treatments of schizophrenia. | Maksymetz J et al. | β | 2017 | β |
| Testing a decades' old assumption: Are individuals with lower sensory gating indeed more easily distracted? | Bak N et al. | β | 2017 | β |
| The Application of Multiplex Biomarker Techniques for Improved Stratification and Treatment of Schizophrenia Patients. | Steiner J et al. | β | 2017 | β |
| The association between season of birth, age at onset, and clozapine use in schizophrenia. | Kim JS et al. | β | 2017 | β |
| The catecholaminergic neurotransmitter system in methylmercury-induced neurotoxicity. | Farina M et al. | β | 2017 | β |
| The contribution of rare variants to risk of schizophrenia in individuals with and without intellectual disability. | Singh T et al. | β | 2017 | β |
| The Intricate Relationship between Psychotic-Like Experiences and Associated Subclinical Symptoms in Healthy Individuals. | Unterrassner L et al. | β | 2017 | β |
| The phosphodiesterase 10A selective inhibitor, TAK-063, induces c-Fos expression in both direct and indirect pathway medium spiny neurons and sub-regions of the medial prefrontal cortex in rats. | Nakatani A et al. | β | 2017 | β |
| The role of life context and self-defined well-being in the outcomes that matter to people with a diagnosis of schizophrenia. | Lloyd H et al. | β | 2017 | β |
| Treating schizophrenia during menopause. | Brzezinski A et al. | β | 2017 | β |
| Tumor necrosis factor-Ξ± and -Ξ² genetic polymorphisms as a risk factor in Saudi patients with schizophrenia. | Kadasah S et al. | β | 2017 | β |
| Two-stage integrated care versus antipsychotic medication alone on outcomes of schizophrenia: One-year randomized controlled trial and follow-up. | She S et al. | β | 2017 | β |
| Wendan decoction (Traditional Chinese medicine) for schizophrenia. | Deng H et al. | β | 2017 | β |
| Yoga as part of a package of care versus standard care for schizophrenia. | Broderick J et al. | β | 2017 | β |
| Yoga versus non-standard care for schizophrenia. | Broderick J et al. | β | 2017 | β |
| ABC transporters P-gp and Bcrp do not limit the brain uptake of the novel antipsychotic and anticonvulsant drug cannabidiol in mice. | Brzozowska N et al. | β | 2016 | β |
| Aberrant Expression of Long Non-Coding RNAs in Schizophrenia Patients. | Chen S et al. | β | 2016 | β |
| Abnormalities in neuroendocrine stress response in psychosis: the role of endocannabinoids. | Appiah-Kusi E et al. | β | 2016 | β |
| A Case Study on Promoting Neuroplasticity in a Patient With Schizophrenia. | Puskar K et al. | β | 2016 | β |
| African-American representation in family and twin studies of mood and anxiety disorders: A systematic review. | Murphy E | β | 2016 | β |
| A functional variant in MIR137, a candidate gene for schizophrenia, affects Stroop test performance in young adults. | GonzΓ‘lez-Giraldo Y et al. | β | 2016 | β |
| A heuristic model for working memory deficit in schizophrenia. | Qi Z et al. | β | 2016 | β |
| Analyzing the Role of MicroRNAs in Schizophrenia in the Context of Common Genetic Risk Variants. | Hauberg ME et al. | β | 2016 | β |
| An Association Study Between Genetic Polymorphisms in Functional Regions of Five Genes and the Risk of Schizophrenia. | Yan P et al. | β | 2016 | β |
| Are Specific Early-Life Adversities Associated With Specific Symptoms of Psychosis?: A Patient Study Considering Just World Beliefs as a Mediator. | Wickham S et al. | β | 2016 | β |
| Asperger Syndrome and Schizophrenia: A Comparative Neuropsychological Study. | Marinopoulou M et al. | β | 2016 | β |
| Assessing the impact on caregivers of patients with schizophrenia: psychometric validation of the Schizophrenia Caregiver Questionnaire (SCQ). | Rofail D et al. | β | 2016 | β |
| Association between PLA2G12A Polymorphisms and Schizophrenia in a Han Chinese Population from Northeast China. | Yang G et al. | β | 2016 | β |
| Association studies of genomic variants with treatment response to risperidone, clozapine, quetiapine and chlorpromazine in the Chinese Han population. | Xu Q et al. | β | 2016 | β |
| A study of single nucleotide polymorphisms of GRIN2B in schizophrenia from Chinese Han population. | Guo Z et al. | β | 2016 | β |
| A systematic review of cognitive failures in daily life: Healthy populations. | Carrigan N et al. | β | 2016 | β |
| Atypical antipsychotic treatment increases glial cell line-derived neurotrophic factor serum levels in drug-free schizophrenic patients along with improvement of psychotic symptoms and therapeutic effects. | Xiao W et al. | β | 2016 | β |
| Autoantibodies in Neuropsychiatric Disorders. | Hoffmann C et al. | β | 2016 | β |
| Baseline Striatal Functional Connectivity as a Predictor of Response to Antipsychotic Drug Treatment. | Sarpal DK et al. | β | 2016 | β |
| Bifeprunox versus placebo for schizophrenia. | Chattopadhyay A et al. | β | 2016 | β |
| Brain activity and connectivity in response to negative affective stimuli: Impact of dysphoric mood and sex across diagnoses. | Mareckova K et al. | β | 2016 | β |
| Brain structural changes in schizoaffective disorder compared to schizophrenia and bipolar disorder. | Amann BL et al. | β | 2016 | β |
| Bridging the Gap between Genes and Language Deficits in Schizophrenia: An Oscillopathic Approach. | Murphy E et al. | β | 2016 | β |
| Cannabidiol, among Other Cannabinoid Drugs, Modulates Prepulse Inhibition of Startle in the SHR Animal Model: Implications for Schizophrenia Pharmacotherapy. | Peres FF et al. | β | 2016 | β |
| Cannabis, Psychosis, and Mortality: A Cohort Study of 50,373 Swedish Men. | Manrique-Garcia E et al. | β | 2016 | β |
| Cannabis Use Is Associated With Increased Psychotic Symptoms and Poorer Psychosocial Functioning in First-Episode Psychosis: A Report From the UK National EDEN Study. | Seddon JL et al. | β | 2016 | β |
| Celecoxib Adjunctive Treatment to Antipsychotics in Schizophrenia: A Review of Randomized Clinical Add-On Trials. | Marini S et al. | β | 2016 | β |
| Clinical studies of neuroinflammatory mechanisms in schizophrenia. | Watkins CC et al. | β | 2016 | β |
| Cognition and psychopathology in first-episode psychosis: are they related to inflammation? | Cabrera B et al. | β | 2016 | β |
| Cognitive behavioral therapy in 22q11.2 microdeletion with psychotic symptoms: What do we learn from schizophrenia? | Demily C et al. | β | 2016 | β |
| Comparison of Subjective Experiences and Effectiveness of First-Generation Long-Acting Injectable Antipsychotics and Risperidone Long-Acting Injectables in Patients With Schizophrenia. | Chen WY et al. | β | 2016 | β |
| Correlation Between Brain Activation Changes and Cognitive Improvement Following Cognitive Remediation Therapy in Schizophrenia: An Activation Likelihood Estimation Meta-analysis. | Wei YY et al. | β | 2016 | β |
| Critical appraisal of 3-monthly paliperidone depot injections in the treatment of schizophrenia. | Carpiniello B et al. | β | 2016 | β |
| Current trends in autoimmunity and the nervous system. | Selmi C et al. | β | 2016 | β |
| Delaware CORE: Early Psychosis Prevention in the First State. | Webb C et al. | β | 2016 | β |
| Detection of changes in the ventral tegmental area of patients with schizophrenia using neuromelanin-sensitive MRI. | Yamashita F et al. | β | 2016 | β |
| Determination of Drugs in Plasma Samples by High-Performance Liquid Chromatography-Tandem Mass Spectrometry for Therapeutic Drug Monitoring of Schizophrenic Patients. | Domingues DS et al. | β | 2016 | β |
| Developmental timing and critical windows for the treatment of psychiatric disorders. | MarΓn O | β | 2016 | β |
| Development of 1<i>H</i>-Pyrazolo[3,4-<i>b</i>]pyridines as Metabotropic Glutamate Receptor 5 Positive Allosteric Modulators. | Hill MD et al. | β | 2016 | β |
| Development of Molecularly Imprinted Olanzapine Nano-particles: In Vitro Characterization and In Vivo Evaluation. | Jafary Omid N et al. | β | 2016 | β |
| Differences among first-episode schizophrenia patients, healthy siblings, and controls at the individual level. | Ou J et al. | β | 2016 | β |
| Differential blood-based biomarkers of psychopathological dimensions of schizophrenia. | Garcia-Alvarez L et al. | β | 2016 | β |
| Differential Patterns of Dysconnectivity in Mirror Neuron and Mentalizing Networks in Schizophrenia. | Schilbach L et al. | β | 2016 | β |
| Difluorocyclobutylacetylenes as positive allosteric modulators of mGluR5 with reduced bioactivation potential. | Degnan AP et al. | β | 2016 | β |
| Discovery and Preclinical Evaluation of BMS-955829, a Potent Positive Allosteric Modulator of mGluR5. | Yang F et al. | β | 2016 | β |
| Discovery of pyrazolopyrimidine phosphodiesterase 10A inhibitors for the treatment of schizophrenia. | Raheem IT et al. | β | 2016 | β |
| Distinct white-matter aberrations in 22q11.2 deletion syndrome and patients at ultra-high risk for psychosis. | Bakker G et al. | β | 2016 | β |
| Effectiveness of rivastigmine on positive, negative, and cognitive symptoms of schizophrenia: a double-blind clinical trial. | Shoja Shafti S et al. | β | 2016 | β |
| Effects of a novel phosphodiesterase 10A inhibitor in non-human primates: A therapeutic approach for schizophrenia with improved side effect profile. | Masilamoni GJ et al. | β | 2016 | β |
| Effects of Relaxation Exercises and Music Therapy on the Psychological Symptoms and Depression Levels of Patients with Schizophrenia. | Kavak F et al. | β | 2016 | β |
| Efficacy and safety of adjunctive bitopertin versus placebo in patients with suboptimally controlled symptoms of schizophrenia treated with antipsychotics: results from three phase 3, randomised, double-blind, parallel-group, placebo-controlled, multicentre studies in the SearchLyte clinical trial programme. | Bugarski-Kirola D et al. | β | 2016 | β |
| Efficacy and Safety of Antidepressants Added to Antipsychotics for Schizophrenia: A Systematic Review and Meta-Analysis. | Helfer B et al. | β | 2016 | β |
| Efficacy and safety of asenapine in Asian patients with an acute exacerbation of schizophrenia: a multicentre, randomized, double-blind, 6-week, placebo-controlled study. | Kinoshita T et al. | β | 2016 | β |
| Employing proteomics to unravel the molecular effects of antipsychotics and their role in schizophrenia. | Cassoli JS et al. | β | 2016 | β |
| Epigenetic Treatment of Neuropsychiatric Disorders: Autism and Schizophrenia. | Moos WH et al. | β | 2016 | β |
| Evaluation of the validity and utility of a transdiagnostic psychosis dimension encompassing schizophrenia and bipolar disorder. | Reininghaus U et al. | β | 2016 | β |
| Exploring the presence of narcolepsy in patients with schizophrenia. | Sansa G et al. | β | 2016 | β |
| Extent and pattern of burden of care and its associated factors among Eritrean families of persons living with schizophrenia: a cross-sectional study. | Hidru TH et al. | β | 2016 | β |
| Family burden in schizophrenia: the influence of age of onset and negative symptoms. | Mantovani LM et al. | β | 2016 | β |
| From Shortage to Surge: A Developmental Switch in Hippocampal-Prefrontal Coupling in a Gene-Environment Model of Neuropsychiatric Disorders. | Hartung H et al. | β | 2016 | β |
| Functional Characterization of Schizophrenia-Associated Variation in CACNA1C. | Eckart N et al. | β | 2016 | β |
| Functional Effects of Schizophrenia-Linked Genetic Variants on Intrinsic Single-Neuron Excitability: A Modeling Study. | MΓ€ki-Marttunen T et al. | β | 2016 | β |
| Fusing Sensor Paradigms to Acquire Chemical Information: An Integrative Role for Smart Biopolymeric Hydrogels. | Kim E et al. | β | 2016 | β |
| Gene Γ Environment Interactions in Schizophrenia: Evidence from Genetic Mouse Models. | Moran P et al. | β | 2016 | β |
| Genome-wide association analysis to predict optimal antipsychotic dosage in schizophrenia: a pilot study. | Koga AT et al. | β | 2016 | β |
| Genome-wide association study with the risk of schizophrenia in a Korean population. | Kim LH et al. | β | 2016 | β |
| Gesture Performance in Schizophrenia Predicts Functional Outcome After 6 Months. | Walther S et al. | β | 2016 | β |
| Health-related quality of life in patients with prominent negative symptoms: results from a multicenter randomized Phase II trial on bitopertin. | Rofail D et al. | β | 2016 | β |
| Hepatic Safety of Atypical Antipsychotics: Current Evidence and Future Directions. | Slim M et al. | β | 2016 | β |
| Hesitation Wounds and Sharp Force Injuries in Forensic Pathology and Psychiatry: Multidisciplinary Review of the Literature and Study of Two Cases. | Karakasi MV et al. | β | 2016 | β |
| Hippocampal Pruning as a New Theory of Schizophrenia Etiopathogenesis. | Cocchi E et al. | β | 2016 | β |
| Hospital utilization outcome of an assertive outreach model for schizophrenic patients - results of a quasi-experimental study. | BΓΌchtemann D et al. | β | 2016 | β |
| Hypothyroxinemia During Gestation and Offspring Schizophrenia in a National Birth Cohort. | Gyllenberg D et al. | β | 2016 | β |
| Impairments in dendrite morphogenesis as etiology for neurodevelopmental disorders and implications for therapeutic treatments. | Copf T | β | 2016 | β |
| Improvements and important considerations for the 5-choice serial reaction time task-An effective measurement of visual attention in rats. | Bhandari J et al. | β | 2016 | β |
| Improving classification of psychoses. | Lawrie SM et al. | β | 2016 | β |
| Improving our understanding of the <i>in vivo</i> modelling of psychotic disorders: A protocol for a systematic review and meta-analysis. | Bahor Z et al. | β | 2016 | β |
| Improving the Physical Health Monitoring of City & Hackney Assertive Outreach Service Patients. | Akyuz E et al. | β | 2016 | β |
| Induction Immunosuppression in High-risk Kidney Transplant Recipients. | Buttigieg J et al. | β | 2016 | β |
| Insight and recovery in schizophrenic patients. | CannavΓ² D et al. | β | 2016 | β |
| Interaction of multiple gene variants and their effects on schizophrenia phenotypes. | Cheah SY et al. | β | 2016 | β |
| Is schizophrenia disappearing? The rise and fall of the diagnosis of functional psychoses: an essay. | Bergsholm P | β | 2016 | β |
| Kynurenines, Gender and Neuroinflammation; Showcase Schizophrenia. | de Bie J et al. | β | 2016 | β |
| Life satisfaction and happiness among young adults with schizophrenia. | Fervaha G et al. | β | 2016 | β |
| Longitudinal Changes in Resting-State Cerebral Activity in Patients with First-Episode Schizophrenia: A 1-Year Follow-up Functional MR Imaging Study. | Li F et al. | β | 2016 | β |
| [Management of eating disorders in schizophrenia]. | Kouidrat Y et al. | β | 2016 | β |
| Mean kurtosis alterations of cerebral white matter in patients with schizophrenia revealed by diffusion kurtosis imaging. | Narita H et al. | β | 2016 | β |
| Mental health service utilisation after a Community Treatment Order: A comparison between three modes of termination. | Vine R et al. | β | 2016 | β |
| Meta-analysis of sex differences in gene expression in schizophrenia. | Qin W et al. | β | 2016 | β |
| Metabotropic glutamate receptors as targets for new antipsychotic drugs: Historical perspective and critical comparative assessment. | WieroΕska JM et al. | β | 2016 | β |
| Might Hallucinations Have Social Utility?: A Proposal for Scientific Study. | Kauffman PR | β | 2016 | β |
| Mindfulness- and Acceptance-based Interventions for Psychosis: A Systematic Review and Meta-analysis. | Cramer H et al. | β | 2016 | β |
| Molecular Signatures of Psychosocial Stress and Cognition Are Modulated by Chronic Lithium Treatment. | BrzΓ³zka MM et al. | β | 2016 | β |
| Molecular substrates of schizophrenia: homeostatic signaling to connectivity. | Landek-Salgado MA et al. | β | 2016 | β |
| Multiprobe molecular imaging of an NMDA receptor hypofunction rat model for glutamatergic dysfunction. | Kosten L et al. | β | 2016 | β |
| Neural correlates of reward processing in adults with 22q11 deletion syndrome. | van Duin EDA et al. | β | 2016 | β |
| Neural substrates underlying delusions in schizophrenia. | Zhu J et al. | β | 2016 | β |
| Neuropsychological and neuroimaging underpinnings of schizoaffective disorder: a systematic review. | Madre M et al. | β | 2016 | β |
| Olanzapine pamoate for the treatment of schizophrenia--a safety evaluation. | Samalin L et al. | β | 2016 | β |
| Once-monthly paliperidone palmitate compared with conventional and atypical daily oral antipsychotic treatment in patients with schizophrenia. | Kim E et al. | β | 2016 | β |
| Plasma metabonomics study of first-Episode schizophrenia treated with olanzapine in female patients. | Qiao Y et al. | β | 2016 | β |
| Polygenic Risk of Schizophrenia and Cognition in a Population-Based Survey of Older Adults. | Liebers DT et al. | β | 2016 | β |
| Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review. | TrΓ©panier MO et al. | β | 2016 | β |
| Preliminary Effectiveness and Sustainability of Group Aerobic Exercise Program in Patients with Schizophrenia. | Yoon S et al. | β | 2016 | β |
| Prenatal immune activation in mice blocks the effects of environmental enrichment on exploratory behavior and microglia density. | Buschert J et al. | β | 2016 | β |
| Prevalence and correlates of psychotic experiences amongst children of depressed parents. | Bevan Jones R et al. | β | 2016 | β |
| Prevalence of late potentials on signal-averaged ECG in patients with psychiatric disorders. | Antoniou CK et al. | β | 2016 | β |
| Progesterone: The neglected hormone in schizophrenia? A focus on progesterone-dopamine interactions. | Sun J et al. | β | 2016 | β |
| Proteome effects of antipsychotic drugs: Learning from preclinical models. | Carboni L et al. | β | 2016 | β |
| Psychosis as a transdiagnostic and extended phenotype in the general population. | van Os J et al. | β | 2016 | β |
| Psychotic-like experiences and disordered eating in the English general population. | Koyanagi A et al. | β | 2016 | β |
| Purinergic receptors in psychiatric disorders. | KrΓΌgel U | β | 2016 | β |
| Rare loss-of-function variants in SETD1A are associated with schizophrenia and developmental disorders. | Singh T et al. | β | 2016 | β |
| Rare UNC13B variations and risk of schizophrenia: Whole-exome sequencing in a multiplex family and follow-up resequencing and a case-control study. | Egawa J et al. | β | 2016 | β |
| Relationship between negative symptoms and neurocognitive functions in adolescent and adult patients with first-episode schizophrenia. | Huang M et al. | β | 2016 | β |
| Relationship between neutrophil/lymphocyte ratio with oxidative stress and psychopathology in patients with schizophrenia. | Kulaksizoglu B et al. | β | 2016 | β |
| Relationship between ST8SIA2, polysialic acid and its binding molecules, and psychiatric disorders. | Sato C et al. | β | 2016 | β |
| Rethinking Schizophrenia in the Context of the Person and Their Circumstances: Seven Reasons. | PΓ©rez-Γlvarez M et al. | β | 2016 | β |
| Schizophrenia. | Owen MJ et al. | β | 2016 | β |
| Schizophrenia and neurosurgery: A dark past with hope of a brighter future. | Agarwal P et al. | β | 2016 | β |
| Schizophrenia: Impact of psychopathology, faith healers and psycho-education on adherence to medications. | Abdel Aziz K et al. | β | 2016 | β |
| Schizophrenia treatment: an obstacle course. | Zink M et al. | β | 2016 | β |
| Self-deception as affective coping. An empirical perspective on philosophical issues. | Lauria F et al. | β | 2016 | β |
| Self is "other", other is "self": poor self-other discriminability explains schizotypal twisted agency judgment. | Asai T | β | 2016 | β |
| Socioeconomic status at birth and risk for first episode psychosis in rural Ireland: Eliminating the features of urbanicity in the Cavan-Monaghan First Episode Psychosis Study (CAMFEPS). | Omer S et al. | β | 2016 | β |
| Spatial distribution of psychotic disorders in an urban area of France: an ecological study. | Pignon B et al. | β | 2016 | β |
| Sub-chronic Antipsychotic Drug Administration Reverses the Expression of Neuregulin 1 and ErbB4 in a Cultured MK801-Induced Mouse Primary Hippocampal Neuron or a Neurodevelopmental Schizophrenia Model. | Li C et al. | β | 2016 | β |
| Targets, attitudes, and goals of psychiatrists treating patients with schizophrenia: key outcome drivers, role of quality of life, and place of long-acting antipsychotics. | de Bartolomeis A et al. | β | 2016 | β |
| Tcf4 transgenic female mice display delayed adaptation in an auditory latent inhibition paradigm. | BrzΓ³zka MM et al. | β | 2016 | β |
| TDO as a therapeutic target in brain diseases. | Yu CP et al. | β | 2016 | β |
| The CHRM3 gene is implicated in abnormal thalamo-orbital frontal cortex functional connectivity in first-episode treatment-naive patients with schizophrenia. | Wang Q et al. | β | 2016 | β |
| The Effect of Yoga on Functional Recovery Level in Schizophrenic Patients. | Kavak F et al. | β | 2016 | β |
| [The German research network for mental disorders]. | Bauer M et al. | β | 2016 | β |
| The implications of the shared genetics of psychiatric disorders. | O'Donovan MC et al. | β | 2016 | β |
| The known and missing links between Toxoplasma gondii and schizophrenia. | Elsheikha HM et al. | β | 2016 | β |
| The Neonatal Ventral Hippocampal Lesion (NVHL) Rodent Model of Schizophrenia. | Brady AM | β | 2016 | β |
| The Phosphodiesterase 10A Selective Inhibitor TAK-063 Improves Cognitive Functions Associated with Schizophrenia in Rodent Models. | Shiraishi E et al. | β | 2016 | β |
| The serum level of C-reactive protein (CRP) is associated with cognitive performance in acute phase psychosis. | Johnsen E et al. | β | 2016 | β |
| Towards a second-person neuropsychiatry. | Schilbach L | β | 2016 | β |
| Two-stage replication of previous genome-wide association studies of AS3MT-CNNM2-NT5C2 gene cluster region in a large schizophrenia case-control sample from Han Chinese population. | Guan F et al. | β | 2016 | β |
| Using the Young Mania Rating Scale for Identifying Manic Symptoms in Patients with Schizophrenia. | Park SC et al. | β | 2016 | β |
| Vitamin D in schizophrenia: a clinical review. | Chiang M et al. | β | 2016 | β |
| Wendan decoction (ζΈ©θζ±€) for treatment of schizophrenia: a systematic review of randomized controlled trials. | Che YW et al. | β | 2016 | β |
| Whether "psychosis" is best conceptualized as a continuum or in categories is an empirical, practical and political question. | Lawrie SM | β | 2016 | β |
| Abnormal inter- and intra-hemispheric integration in male paranoid schizophrenia: a graph-theoretical analysis. | Chen J et al. | β | 2015 | β |
| A brief intervention to improve exercising in patients with schizophrenia: a controlled pilot study with mental contrasting and implementation intentions (MCII). | Sailer P et al. | β | 2015 | β |
| A Cost-effectiveness Analysis of Antipsychotics for Treatment of Schizophrenia in Uganda. | Lubinga SJ et al. | β | 2015 | β |
| Advanced glycation end products and schizophrenia: A systematic review. | Kouidrat Y et al. | β | 2015 | β |
| Altered resting-state EEG source functional connectivity in schizophrenia: the effect of illness duration. | Di Lorenzo G et al. | β | 2015 | β |
| A national population-based e-cohort of people with psychosis (PsyCymru) linking prospectively ascertained phenotypically rich and genetic data to routinely collected records: overview, recruitment and linkage. | Lloyd K et al. | β | 2015 | β |
| A New Perspective on Delusional Statesβ-βEvidence for Claustrum Involvement. | Patru MC et al. | β | 2015 | β |
| Angiogenesis in the pathophysiology of schizophrenia - a comprehensive review and a conceptual hypothesis. | Lopes R et al. | β | 2015 | β |
| An Integrated Care Initiative to Improve Patient Outcome in Schizophrenia. | Mayer-Amberg N et al. | β | 2015 | β |
| Apolipoprotein E polymorphism is associated with susceptibility to schizophrenia among Saudis. | Al-Asmary SM et al. | β | 2015 | β |
| A social path to functioning in schizophrenia: From social self-efficacy through negative symptoms to social functional capacity. | Vaskinn A et al. | β | 2015 | β |
| Association between NR4A2 genetic variation and schizophrenia: A comprehensive systematic review and meta-analysis. | Liu H et al. | β | 2015 | β |
| Association of single-nucleotide polymorphism of cholecystokinin receptor A gene with schizophrenia in an Eastern Indian population. | Rout JK et al. | β | 2015 | β |
| Association study of BCL9 gene polymorphism rs583583 with schizophrenia and negative symptoms in Japanese population. | Kimura H et al. | β | 2015 | β |
| Association study of sepiapterin reductase gene promoter polymorphisms with schizophrenia in a Han Chinese population. | Fu J et al. | β | 2015 | β |
| Asymmetric dimethylarginine levels in patients with schizophrenia. | Balta S et al. | β | 2015 | β |
| A systematic review of the antipsychotic properties of cannabidiol in humans. | Iseger TA et al. | β | 2015 | β |
| Attitudes toward Placebo-Controlled Clinical Trials of Patients with Schizophrenia in Japan. | Sugawara N et al. | β | 2015 | β |
| Beyond the association. Toxoplasma gondii in schizophrenia, bipolar disorder, and addiction: systematic review and meta-analysis. | Sutterland AL et al. | β | 2015 | β |
| Changes in neurocognitive functioning during transition to manifest disease: comparison of individuals at risk for schizophrenic and bipolar affective psychoses. | Metzler S et al. | β | 2015 | β |
| Chemotherapy for Hodgkin's lymphoma in a patient receiving clozapine for treatment-resistant schizophrenia: use of the Mental Capacity Act 2005. | Chamberlain FE et al. | β | 2015 | β |
| Clinical correlates of superior temporal gyrus volume abnormalities in antipsychotic-naΓ―ve schizophrenia. | Narayanaswamy JC et al. | β | 2015 | β |
| Cognitive mapping deficits in schizophrenia: Evidence from clinical correlates of visuospatial transformations. | Agarwal SM et al. | β | 2015 | β |
| Comparison of grey matter volume and thickness for analysing cortical changes in chronic schizophrenia: a matter of surface area, grey/white matter intensity contrast, and curvature. | Kong L et al. | β | 2015 | β |
| Cross-cultural adaptation of the Schizophrenia Caregiver Questionnaire (SCQ) and the Caregiver Global Impression (CaGI) Scales in 11 languages. | Rofail D et al. | β | 2015 | β |
| Current Update on Synopsis of miRNA Dysregulation in Neurological Disorders. | Kamal MA et al. | β | 2015 | β |
| Cytoarchitectural and functional abnormalities of the inferior colliculus in sudden unexplained perinatal death. | Lavezzi AM et al. | β | 2015 | β |
| Deletion of Metabotropic Glutamate Receptors 2 and 3 (mGlu2 & mGlu3) in Mice Disrupts Sleep and Wheel-Running Activity, and Increases the Sensitivity of the Circadian System to Light. | Pritchett D et al. | β | 2015 | β |
| Dermatoglyphic correlates of hippocampus volume: Evaluation of aberrant neurodevelopmental markers in antipsychotic-naΓ―ve schizophrenia. | Kalmady SV et al. | β | 2015 | β |
| Dietary patterns and schizophrenia: a comparison with healthy controls. | Tsuruga K et al. | β | 2015 | β |
| Discovery and Optimization of a Series of Pyrimidine-Based Phosphodiesterase 10A (PDE10A) Inhibitors through Fragment Screening, Structure-Based Design, and Parallel Synthesis. | Shipe WD et al. | β | 2015 | β |
| Effect of time and duration of untreated psychosis on cognitive and social functioning in Chinese patients with first-episode schizophrenia: A 1-year study. | Heeramun-Aubeeluck A et al. | β | 2015 | β |
| Efficacy and Safety of Brexpiprazole for the Treatment of Acute Schizophrenia: A 6-Week Randomized, Double-Blind, Placebo-Controlled Trial. | Correll CU et al. | β | 2015 | β |
| Efficacy, tolerability, and safety of aripiprazole once-monthly versus other long-acting injectable antipsychotic therapies in the maintenance treatment of schizophrenia: a mixed treatment comparison of double-blind randomized clinical trials. | Majer IM et al. | β | 2015 | β |
| Elevated serum immunoinflammation-related protein complexes are associated with psychosis. | Liu Y et al. | β | 2015 | β |
| Emotion processing deficits: a liability spectrum providing insight into comorbidity of mental disorders. | Kret ME et al. | β | 2015 | β |
| Employment and the associated impact on quality of life in people diagnosed with schizophrenia. | Bouwmans C et al. | β | 2015 | β |
| EPA guidance on the early detection of clinical high risk states of psychoses. | Schultze-Lutter F et al. | β | 2015 | β |
| Epidemiology and Treatment Guidelines of Negative Symptoms in Schizo-phrenia in Central and Eastern Europe: A Literature Review. | Szkultecka-DΔbek M et al. | β | 2015 | β |
| Epigenetic signaling in schizophrenia. | Ibi D et al. | β | 2015 | β |
| Evaluating the relationship between reelin gene variants (rs7341475 and rs262355) and schizophrenia: A meta-analysis. | Li W et al. | β | 2015 | β |
| Evaluation of the pharmacokinetics, safety and clinical efficacy of ziprasidone for the treatment of schizophrenia and bipolar disorder. | Mandrioli R et al. | β | 2015 | β |
| Expanding the clinical spectrum of hereditary fibrosing poikiloderma with tendon contractures, myopathy and pulmonary fibrosis due to FAM111B mutations. | Mercier S et al. | β | 2015 | β |
| Experimental validation of candidate schizophrenia gene CALN1 as a target for microRNA-137. | Xia S et al. | β | 2015 | β |
| Feasibility and acceptability of patient partnership to improve access to primary care for the physical health of patients with severe mental illnesses: an interactive guide. | Pelletier JF et al. | β | 2015 | β |
| [Frontal brain volume reduction due to antipsychotic drugs?]. | Aderhold V et al. | β | 2015 | β |
| Fronto-striatal dysfunction during reward processing in unaffected siblings of schizophrenia patients. | de Leeuw M et al. | β | 2015 | β |
| Functional deterioration from the premorbid period to 2 years after the first episode of psychosis in early-onset psychosis. | Del Rey-MejΓas Γ et al. | β | 2015 | β |
| Further evidence supporting the association of NKAPL with schizophrenia. | Wang Z et al. | β | 2015 | β |
| Glutamatergic agents for schizophrenia: current evidence and perspectives. | Zink M et al. | β | 2015 | β |
| Healthcare utilization and costs of Veterans Health Administration patients with schizophrenia treated with paliperidone palmitate long-acting injection or oral atypical antipsychotics. | Baser O et al. | β | 2015 | β |
| Hijacked in cancer: the KMT2 (MLL) family of methyltransferases. | Rao RC et al. | β | 2015 | β |
| Identification and functional characterization of rare SHANK2 variants in schizophrenia. | Peykov S et al. | β | 2015 | β |
| Improved identification of people at risk of psychosis: is it value for money? | Kearns B | β | 2015 | β |
| Inflammation in schizophrenia: A question of balance. | Leza JC et al. | β | 2015 | β |
| Inhibition of 14-3-3 Proteins Leads to Schizophrenia-Related Behavioral Phenotypes and Synaptic Defects in Mice. | Foote M et al. | β | 2015 | β |
| Initiation of aripiprazole once-monthly in patients with schizophrenia. | Raoufinia A et al. | β | 2015 | β |
| Investigation into effects of antipsychotics on ectonucleotidase and adenosine deaminase in zebrafish brain. | Seibt KJ et al. | β | 2015 | β |
| In vivo pharmacological characterization of TAK-063, a potent and selective phosphodiesterase 10A inhibitor with antipsychotic-like activity in rodents. | Suzuki K et al. | β | 2015 | β |
| Jumping to conclusions in schizophrenia. | Evans SL et al. | β | 2015 | β |
| Ketamine-Induced Changes in the Signal and Noise of Rule Representation in Working Memory by Lateral Prefrontal Neurons. | Ma L et al. | β | 2015 | β |
| Long-term trajectories of positive and negative symptoms in first episode psychosis: A 10year follow-up study in the OPUS cohort. | Austin SF et al. | β | 2015 | β |
| Magnetic resonance imaging and the prediction of outcome in first-episode schizophrenia: a review of current evidence and directions for future research. | Dazzan P et al. | β | 2015 | β |
| Metacognitive training for schizophrenia: a systematic review. | Jiang J et al. | β | 2015 | β |
| Microvascular dysfunction in schizophrenia: a case-control study. | Vetter MW et al. | β | 2015 | β |
| Mitochondrial dysfunction in schizophrenia: pathways, mechanisms and implications. | Rajasekaran A et al. | β | 2015 | β |
| MK-801 treatment affects glycolysis in oligodendrocytes more than in astrocytes and neuronal cells: insights for schizophrenia. | Guest PC et al. | β | 2015 | β |
| Modeling a model: Mouse genetics, 22q11.2 Deletion Syndrome, and disorders of cortical circuit development. | Meechan DW et al. | β | 2015 | β |
| Modeling the budget impact of long-acting injectable paliperidone palmitate in the treatment of schizophrenia in Japan. | Mahlich J et al. | β | 2015 | β |
| Molecular modeling and docking study on dopamine D2-like and serotonin 5-HT2A receptors. | Duan X et al. | β | 2015 | β |
| Needs of Hospitalized Schizophrenic Patients in the North Moravia and the Czech Part of Silesia. | HosΓ‘kovΓ‘ J et al. | β | 2015 | β |
| Negative cognition, affect, metacognition and dimensions of paranoia in people at ultra-high risk of psychosis: a multi-level modelling analysis. | Morrison AP et al. | β | 2015 | β |
| Neurochemical Metabolomics Reveals Disruption to Sphingolipid Metabolism Following Chronic Haloperidol Administration. | McClay JL et al. | β | 2015 | β |
| Neuropsychological characteristics of verbal and non-verbal fluency in schizophrenia patients. | Tyburski E et al. | β | 2015 | β |
| "No more a child, not yet an adult": studying social cognition in adolescence. | Brizio A et al. | β | 2015 | β |
| Nonlinear parameters of surface EMG in schizophrenia patients depend on kind of antipsychotic therapy. | Meigal AY et al. | β | 2015 | β |
| Optimal duration of an early intervention programme for first-episode psychosis: randomised controlled trial. | Chang WC et al. | β | 2015 | β |
| Overview of Glutamatergic Dysregulation in Central Pathologies. | Miladinovic T et al. | β | 2015 | β |
| Paliperidone extended-release tablets in Chinese patients with schizophrenia: meta-analysis of randomized controlled trials. | Cai S et al. | β | 2015 | β |
| Paternal age and mental health of offspring. | Malaspina D et al. | β | 2015 | β |
| Prevalence of psychotic disorders in an urban area of France. | SzΓΆke A et al. | β | 2015 | β |
| Prevalence of schizophrenia in China between 1990 and 2010. | Chan KY et al. | β | 2015 | β |
| Quality of life is associated with chronic inflammation in schizophrenia: a cross-sectional study. | Faugere M et al. | β | 2015 | β |
| Recovery from psychosis: physical health, antipsychotic medication and the daily dilemmas for mental health nurses. | Bressington D et al. | β | 2015 | β |
| Regulation of ABC efflux transporters at blood-brain barrier in health and neurological disorders. | Qosa H et al. | β | 2015 | β |
| Resequencing of early growth response 2 (EGR2) gene revealed a recurrent patient-specific mutation in schizophrenia. | Hu TM et al. | β | 2015 | β |
| Roles of LIM kinases in central nervous system function and dysfunction. | Cuberos H et al. | β | 2015 | β |
| Schizophrenia. | Kahn RS et al. | β | 2015 | β |
| Schizophrenia Patient or Spiritually Advanced Personality? A Qualitative Case Analysis. | Bhargav H et al. | β | 2015 | β |
| Sleep and circadian rhythm disruption and recognition memory in schizophrenia. | Tam SK et al. | β | 2015 | β |
| Social class at birth and risk of psychosis. | O'Donoghue B et al. | β | 2015 | β |
| Social cognition. | Patin A et al. | β | 2015 | β |
| Structured Walking and Chronic Institutionalized Schizophrenia Inmates: A pilot RCT Study on Quality of Life. | Loh SY et al. | β | 2015 | β |
| Subjective competence breeds overconfidence in errors in psychosis. A hubris account of paranoia. | Moritz S et al. | β | 2015 | β |
| Survival analysis of the use of first and second generation antipsychotics among patients suffering schizophrenia: A nationwide population-based cohort study. | Chen VC et al. | β | 2015 | β |
| Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders. | Parikshak NN et al. | β | 2015 | β |
| Telencephalic neurocircuitry and synaptic plasticity in rodent spatial learning and memory. | Pooters T et al. | β | 2015 | β |
| The association between psychosis and severe pain in community-dwelling adults: Findings from 44 low- and middle-income countries. | Koyanagi A et al. | β | 2015 | β |
| The borderline of bipolar: opinions of patients and lessons for clinicians on the diagnostic conflict. | Richardson E et al. | β | 2015 | β |
| The effects of switching from oral to LAI antipsychotic treatment on subjective experience of schizophrenic and schizoaffective patients: Preliminary results. | Pietrini F et al. | β | 2015 | β |
| The Longitudinal Course of Gross Motor Activity in Schizophrenia - Within and between Episodes. | Walther S et al. | β | 2015 | β |
| The muscarinic system, cognition and schizophrenia. | Carruthers SP et al. | β | 2015 | β |
| The therapeutic potential of Ξ±7 nicotinic acetylcholine receptor (Ξ±7 nAChR) agonists for the treatment of the cognitive deficits associated with schizophrenia. | Beinat C et al. | β | 2015 | β |
| The transdiagnostic dimension of psychosis: implications for psychiatric nosology and research. | VAN Os J | β | 2015 | β |
| The Vicious Cycle of Family Atmosphere, Interpersonal Self-concepts, and Paranoia in Schizophrenia-A Longitudinal Study. | Hesse K et al. | β | 2015 | β |
| Toll-like receptor-2 deficiency induces schizophrenia-like behaviors in mice. | Park SJ et al. | β | 2015 | β |
| Understanding schizophrenia as a disorder of consciousness: biological correlates and translational implications from quantum theory perspectives. | Venkatasubramanian G | β | 2015 | β |
| Understanding the impact of persistent symptoms in schizophrenia: Cross-sectional findings from the Pattern study. | Haro JM et al. | β | 2015 | β |
| Unravelling genes and pathways implicated in working memory of schizophrenia in Han Chinese. | Ren H et al. | β | 2015 | β |
| Use of second-generation antipsychotics in the acute inpatient management of schizophrenia in the Middle East. | Alkhadhari S et al. | β | 2015 | β |
| Visualization analysis of author collaborations in schizophrenia research. | Wu Y et al. | β | 2015 | β |
| What are depressive symptoms in acutely ill patients with schizophrenia spectrum disorder? | Schennach R et al. | β | 2015 | β |
| [What criteria for an ideal antipsychotic treatment?]. | Bordet R | β | 2015 | β |
| Yoga versus standard care for schizophrenia. | Broderick J et al. | β | 2015 | β |
| Zuclopenthixol versus placebo for schizophrenia. | Lacey M et al. | β | 2015 | β |
| Antipsychotic-like effect of minocycline in a rat model. | Dokuyucu R et al. | β | 2014 | β |
| Eating disorders in schizophrenia: implications for research and management. | Kouidrat Y et al. | β | 2014 | β |
| Functional connectivity density alterations in schizophrenia. | Zhuo C et al. | β | 2014 | β |
| Genome-wide methylation profiling of schizophrenia. | Rukova B et al. | β | 2014 | β |
| New approaches to psychiatric diagnostic classification. | Owen MJ | β | 2014 | β |
| Opposite risk patterns for autism and schizophrenia are associated with normal variation in birth size: phenotypic support for hypothesized diametric gene-dosage effects. | Byars SG et al. | β | 2014 | β |
| Proteomic enrichment analysis of psychotic and affective disorders reveals common signatures in presynaptic glutamatergic signaling and energy metabolism. | Gottschalk MG et al. | β | 2014 | β |
| Schizophrenia gene expression profile reverted to normal levels by antipsychotics. | Crespo-Facorro B et al. | β | 2014 | β |
| Targeted multiplexed selected reaction monitoring analysis evaluates protein expression changes of molecular risk factors for major psychiatric disorders. | Wesseling H et al. | β | 2014 | β |
| The Psychosis Recent Onset GRoningen Survey (PROGR-S): defining dimensions and improving outcomes in early psychosis. | Liemburg EJ et al. | β | 2014 | β |